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ABSTRACT 
DNA POLYMERASE IOTA PROMOTES G2/M CHECKPOINT ACTIVATION AND 
GENETIC STABILITY AFTER UV-INDUCED DNA DAMAGE 
By: Lindsey Jay Stallons 
June 3, 2011 
Unrepaired DNA damage poses a serious threat to the genetic stability of a 
replicating cell. One mechanism of tolerating this damage is translesion DNA synthesis 
(TLS), in which an accessory polymerase synthesizes DNA directly across from a 
damaged template. TLS is carried out by polymerase 11 (Pol 11), 1, K, and REV 1 in the Y-
family and Pol i; in the B-family. Pol 11 has the well-characterized ability to perform 
accurate bypass of the most common UV-induced DNA lesion; loss of Pol 11 results in 
hypermutability and severely increased risk of skin cancer. The high mutation frequency 
in Poll1-deficient cells has been attributed to the mutagenic TLS activity of Poll. 
Deletion of Pol 1 in the Poll1-deficient background results in greatly reduced UV-induced 
mutation frequencies, but unexpectedly the double knockout mice develop cancer Jaster 
than mice deficient in Pol 11 alone. This unexpected finding suggests that POll may have 
a cellular role outside of TLS, which we investigated using a gene expression approach. 
Poll-proficient and -deficient cells showed markedly different mRNA and microRNA 
expression changes after UV treatment. Bioinformatics analysis revealed that the G2/M 
checkpoint was the main point of divergence in the transcriptional response. Western 
v 
blotting showed that G2/M markers were increased and G liS markers were decreased 24 
hours after UV treatment in Pol t-proficient cells, indicating an active checkpoint. Loss 
of Pol t reversed these trends. F ACS analysis of cell cycle kinetics showed a time-
dependent increase in the number of aneuploid Pol t-deficient cells after UV treatment; 
this degree of genetic instability was not seen in Pol t-proficient cells. We also examined 
the effects of Pol t on UV carcinogenesis in isogenic mice lacking Xpa, a gene central to 
the repair ofUV-induced DNA damage. Loss of Pol t caused a trend towards reduced 
tumor latency (p=O.057), while Poll1-deficiency caused a highly significant reduction in 
tumor latency (p<O.Ol). These results indicate that Pol t plays a role in G2/M checkpoint 
regulation and suppressing UV carcinogenesis. At the cost of frequent point mutations, 
Pol t could help cells avoid death by resolving stalled replication forks and preventing 
double strand breaks. 
vi 




LIST OF FIGURES IX 
CHAPTER 
I. INTRODUCTION 
II. CELL CYCLE CHECKPOINT REGULATION 30 
INTRODUCTION 30 
MATERIALS AND METHODS 32 
RESULTS 36 
DISCUSSION 53 
III. UV CARCINOGENESIS 60 
INTRODUCTION 69 
MATERIALS AND METHODS 65 
RESULTS 66 
DISCUSSION 69 
IV. BPDE MUTAGENESIS 72 
INTRODUCTION 72 
vii 
MATERIALS AND METHODS 
RESULTS 
DISCUSSION 
V. CONCLUSIONS AND FUTURE DIRECTIONS 
REFERENCES 










LIST OF FIGURES 
FIGURE 
1-1 Regulation of DNA lesion bypasss in Sacchromyces cerevisiae 
1-2 Frequency of 6-thioguanine-resistant clones as a function of survival after UV 
irradiation 




1-4 Immunohistochemical analysis of Pol K, Pol t, and Poll] expression in primary 
gliomas tissues and normal brain tissues 21 
1-5 Nucleotide excision repair 25 
2-1 UV-induced mRNA expression changes in Polr( Poll+/+ and Polr( por/-
cells 37 
2-2 UV -induced microRNA expression changes in Polr( PoiT +/+ and Polr( por/-
cells 38 
2-3 Confirmation of micro arrays by RT-qPCR 40 
2-4 Combining mRNA and microRNA expression datasets 41 
2-5 Polo-like kinase signaling pathway is enriched in gene lists analyzed 43 
2-6 mRNA expression changes of PLK signaling pathway members 24 hours after 
UV 45 
2-7 Alterations in G2/M checkpoint pathway proteins after UV 46 
2-8 UV-induced accumulation of mitotic markers is reversed by Poll-knockout 49 
2-9 Poll-deficient cells display polyploidy after UV treatment 50 
ix 
2-10 Polz-deficient cells display a failure in cytokinesis 52 
3-1 UV spectrum and effects of terrestrial absorption 61 
3-2 Skin Cancer Utrecht-Philadelphia action spectrum for hairless albino mice 62 
3-3 UV -induced carcinogenesis in Xpa-I- mice 67 
3-4 Histopathology of squamous cell carcinoma in Xpa-I- mice 68 
4-1 Loss of Pol 11 or POll does not affect BPDE-induced cytotoxicity 78 




Segments of this chapter were published in the Journal of Nucleic Acids (2010). 
General Introduction 
Tumorigenesis is a multi-step process beginning with the transformation of a 
single cell by the accumulation of at least six distinct characteristics. These include 
infinite lifespan, resistance to anti-growth signals, resistance to apoptosis, autocrine 
production of growth signals, sustained angiogenesis, and tissue invasion [1]. These 
properties are regulated by genes in two categories: protooncogenes and tumor 
suppressors. Protooncogenes are normal cellular genes that can be overexpressed due to 
genetic changes, causing cellular transformation. A tumor suppressor is a gene that 
protects a cell from transformation, and loss of expression of these genes can, in concert 
with other genetic changes, lead to carcinogenesis. 
Most environmental carcinogens induce transformation by causing mutations in 
the DNA that alter the activity of protooncogenes or tumor suppressors. These mutations 
are formed when residual, unrepaired DNA damage stalls progression of the replication 
fork during S phase. Stalled replication forks are most frequently resolved using error-
free mechanisms that include homologous recombination or use of the homologous 
nascent strand as a template. Nevertheless, replication may proceed using the damaged 
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strand as a template in an error-prone process known as translesion DNA synthesis 
(TLS). TLS is defined as the incorporation of a nucleotide across from DNA damage 
followed by extension of the potentially mispaired primer-template, and can be error-free 
or error-prone. 
Cellular commitment to error-free, recombinatorial damage avoidance or error-
prone TLS is modulated by the molecular switch proliferating cell nuclear antigen 
(PCNA) (Fig. 1-1). Bulky DNA lesions can cause blockage of replicative polymerases 
and replication fork stalling. The ubiquitin conjugase/ubiquitin ligase pair Rad6/Rad 18 is 
recruited to stalled replication forks where the proteins catalyze monoubiquitylation of 
PCNA at lysine 164. TLS proteins such as REVI and Pol 11 have increased affinity for 
monoubiquitylated PCNA, which facilitates their recruitment and the completion of TLS 
[2]. In yeast, Rad5 and the MMS2-Ubc13 complex (UBE2V2-UBE2N in humans) can 
catalyze polyubiquitylation of PCNA via lysine 63 of ubiquitin, which blocks TLS and 
activates error-free damage avoidance [3]. Damage avoidance includes template 
switching, during which the nascent DNA strand from the sister duplex is used as an 
undamaged homologous template to replicate past the lesion. Humans express two Rad5 
homologs, SHPRH and HLTF, and both catalyze K-63-linked polyubiquitylation of 
PCNA in human cells [4,5,6,7]. In yeast, Ubc9-Sizl can attach the small ubiquitin-like 
modifier (SUMO) to lysine 164 ofPCNA in a reaction that competes with Rad6/Radl8-
mediated monoubiquitylation. PCNA SUMOylation at K-I64 attracts the helicase Srs2 
and prevents error-prone RAD52-dependent recombination [8]. 
Cells presumably risk mutations caused by TLS to relieve replication fork 
blockage at DNA adducts and to avoid the potential formation of extremely cytotoxic 
2 
double strand breaks (DSB). Although it accounts for less than 10% of all bypass 
synthesis events in yeast [9], the frequency of potentially mutagenic TLS may be as high 
as 50% in higher eukaryotes [10,11,12]. The propensity and mutagenic potential ofTLS 
explain why it is etiologic in most environmentally-induced cancers and has been the 
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Fig. 1-1. Regulation of DNA lesion bypass in Saccharomyces cerevisiae. Replication 
fork stalling causes Rad6-Rad18 recruitment and monoubiquitylation of PCNA, causing 
subsequent recruitment of TLS proteins which preferentially bind monoubiquitylated 
PCNA. Rad5 and the MMS2-Ubc 13 complex can catalyze polyubiquitylation of 
monoubiquitylated PCNA, blocking TLS and activating the error-free damage avoidance 
pathway. In addition, Ubc9-Siz1 can add SUMOylate PCNA in the same position that 
Rad6-Rad18 monoubiquitylate it, blocking TLS and damage avoidance and promoting 
error-prone RAD52-dependent recombination. Reproduced with permission from 
Watson N B et ai, Cancer Lett. 2006 Sep 8;241(1):13-22. Copyright 2006 Elsevier 
Ireland Ltd. 
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TLS is perfonned by a relatively new category of accessory DNA polymerases. 
Polymerase 11 (Pol 11), POll, Pol K, and REVI in the Y-family [13] and Pol 1:; in the B-
family.[ 14, 15] are responsible for most TLS in mammalian cells. These proteins have 
active sites that are larger and more open than those of the high-fidelity replicative DNA 
polymerases (Pol a, 8, and E), allowing accommodation of and synthesis past DNA 
templates with large, helix-distorting lesions [16]. This unique ability to synthesize DNA 
opposite bulky adducts helps cells avoid double strand breaks associated with replication 
fork stalling, but can also lead to mutagenesis by incorrect base addition. It is important 
to note that polymerases in the Y -family are expressed in all three kingdoms of life, 
indicating a critical and evolutionarily conserved role for these proteins [13]. The 
obviously conflicting roles of these enzymes in both preventing and promoting genetic 
instability are reflected in the tight cellular control of the TLS pathway (Fig. 1-1). 
Although extensive in vitro studies have given us a better understanding of their role in 
the cell, much less is known about the function of TLS polymerases in living animals. 
Limited epidemiological studies have been conducted to associate single nucleotide 
polymorphisms (SNPs) in TLS genes with cancer risk in humans [17,18]. Knockout 
mice have been generated for each gene, and carcinogenesis studies are published [19,20] 
or underway. Importantly, studies in mice and humans have shown that TLS 
polymerases, particularly Pol 11, are involved in immunoglobulin gene hypennutation 
[21], which is beyond the scope of this dissertation 
REV1 
REVI was discovered in budding yeast by the Lawrence group in 1989 as a 
component of the Pol 1:; complex [22]. The catalytic activity of REV 1 is limited to 
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insertion of dCMP across from a template dG [23]. The human homolog was cloned in 
1999 and has the same template-dependent dCMP transferase catalytic activity on an 
undamaged template or an abasic site [24]. One locus used in eukaryotic cells to measure 
mutation frequency is HPRT, a gene involved in the purine salvage pathway. In this 
forward mutation assay, cells with loss-of-function mutations in HPRT are resistant to the 
drug 6-thioguanine (TG). REVI is required for carcinogen-induced HPRT mutagenesis 
in human cells [25,26,27], but the catalytic activity appears to be dispensable for the 
induction ofUV -induced mutations [28,29], indicating that this protein probably plays a 
structural rather than catalytic role in UV mutagenesis. 
Cells from mice with a targeted deletion of the BRCAI C-terminal (BRCT) 
homology domain of Rev 1 (Rev1BIB) have a reduced UV-induced mutation frequency at 
the Hprt locus [30]. However, the animals have a paradoxically decreased latency of 
squamous cell carcinoma (SCC) formation and only marginally reduced p53 mutagenesis 
in the skin after UV exposure [20]. Despite Rev 1 BIB cells showing a moderate increase in 
chromatid breaks and exchanges after UV in vitro [30], comparative genomic 
hybriziation ofUV-induced SCC and normal skin DNA reveals no increase in the 
frequency of gross genomic alterations in Rev 1 BIB SCC [20]. If point mutations and 
chromosomal rearrangements are near normal levels in BRCT -deleted Rev 1 BIB mice, what 
is the reason for accelerated SCC development? Acute UV exposure of these Rev 1-
mutant mice induces enhanced Atr signaling, senescence, and apoptosis in the skin. 
However, long-term low-dose UV exposure causes a mitogenic response, as evidenced 
by epidermal hyperplasia, decreased apoptosis, and increased proliferation of CPD-
containing keratinocytes [20]. Based on literature reports of the etiological role oflL-6 
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in carcinogenesis and elevated IL-6 levels in the skin after a single subtoxic UV dose, the 
authors conclude that error-prone TLS ofUV-induced DNA damage is responsible for 
suppressing the proinflammatory, tumor-promoting effects ofUV in the skin. However, 
more direct immunological studies are needed to confirm that Revl suppresses UV-
induced inflammation and tumor suppression. 
REVI has also been implicated in TLS across other types of DNA lesions. 
Benzo[a]pyrene dihydrodiolepoxide (BPDE) is the primary carcinogenic metabolite of 
B[a]P and causes point mutations in a REVI-dependent manner [27,31]. BPDE-induced 
Hprt mutations are dramatically decreased in primary mouse fibroblasts after ribozyme-
mediated Rev i-knockdown. When a plasmid expressing this ribozyme is delivered to the 
lungs of All mice by aerosol nebulization, Revi mRNA is reduced by -5%0 in the 
bronchial epithelium. This targeted gene therapy causes a -40% reduction in the lung 
tumor multiplicity after B[a]P treatment. In addition, only 73% ofribozyme-treated mice 
develop lung adenomas after B[a]P, compared with 100% penetrance in control animals 
[32]. This report highlights the potential for interrupting translesion synthesis as a 
chemoprevention strategy. 
Although no human disorder involving REVi deficiency is known, there are 16 
SNPs in humans that result in nonsynonymous amino acid changes. The F257S SNP, 
which lies outside of all known functional domains of the protein, has been associated 
with an increased risk of squamous cell carcinoma of the lung in patients who have ever 
smoked cigarettes [33]. However, this association remains controversial [34]. The same 
F257S SNP was associated with decreased risk of cervical cancer, and N373S within the 
catalytic domain was associated with increased risk of cervical cancer. Both effects were 
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specific for squamous cell carcinoma and not relevant for adenocarcinoma of the cervix 
[17]. Although the functional consequences of these polymorphisms are unknown, these 
studies support a role for REV 1 in the formation of multiple internal cancers. 
POL Yf 
The study of trans lesion synthesis in mammals began in 1999 with the discovery 
of the molecular defect that results in Xeroderma Pigmentosum (XP) variant syndrome. 
All XP patients have dramatically increased susceptibility to UV-induced skin cancer 
[35]. Patients in complementation groups A through G are deficient in nucleotide 
excision repair (NER), the major pathway for removal of helix-distorting lesions, 
including those induced by UV. However, the XP variant subset of patients has normal 
NER activity [36,37], yet displays the skin cancer-prone phenotype ofNER-deficient 
patients. The XP variant mystery persisted for nearly three decades. Intensive 
investigations indicate that after UV-irradiation cells from these patients have difficulty 
exiting S-phase that is exacerbated by caffeine [38,39]. Further, these cells are extremely 
hypermutable after UV [40]. In 1999, two groups independently discovered that XP 
variant patients carry autosomal recessive mutations in POLR, the human gene coding 
for Pol 11, and that the enzyme can catalyze error-free DNA synthesis across from a 
template TT cyclobutane pyrimidine dimer (CPD) [41,42,43]. The dramatic increase in 
skin cancer risk of XP variant patients could now be explained by the absence of a critical 
translesion DNA polymerase. UV principally induces photoaddition products between 
intrastrand adjacent pyrimidines, the most frequent of which are TT CPD. These lesions 
block progression of the replication fork. Data indicate that helicase activity may 
continue in spite of the blocked replication complex, resulting in single-stranded DNA 
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that is rapidly coated with replication protein A (RP A). This appears to attract the 
ubiquitin ligase RADI8, which has binding sites for the ubiquitin conjugase RAD6, Pol 
11, and RPA. One target of ubi quityl at ion is PCNA. Since Pol 11 has a ubiquitin binding 
domain, Pol 11 is now thought to be preferentially attracted to the stalled fork because it is 
chaperoned directly by RAD 18 and binds to the ubiquitylated PCNA (Fig. I ) [44]. Data 
indicate that Pol 11 then incorporates AA across from TT CPO in the template. In the 
absence of Pol 11, another translesion polymerase, which is potentially error-prone when 
bypassing these common UV-induced lesions, accesses the damaged template(reviewed 
in [2,45]). Generation of Pol 11-knockout mice shows that the highly homologous mouse 
Pol 11 protein functions similarly in UV -induced mutagenesis and carcinogenesis. Pol 11-
deficient mice develop squamous cell carcinoma with 100% penetrance at a UV fluence 
that does not cause any tumors in wild-type littermates. In addition, approximately one-
third of heterozygous mice develop cancer after UV exposure [19]. This raises the 
possibility that humans carrying heterozygous mutations in the POLH gene may have an 
increased risk of developing skin cancer. However, this speculation has not been 
clinically investigated. 
There is evidence that XP variant patients develop internal cancers faster than Pol 
11-proficient individuals [46,47], raising the possibility that Pol 11-deficiency is involved 
in the formation of multiple human cancers caused by DNA damaging agents other than 
UV. Six SNPs in POLHhave been found to date that result in non synonymous amino 
acid substitutions, but their functional significance is unknown. There is a single study 
evaluating the effects on cancer risk of POLH polymorphisms. Flanagan and colleagues 
found no significant changes in coding-region SNPs of POLH among 40 basal cell 
9 
carcinoma and squamous cell carcinoma patients in a fair-skinned Irish population [48]. 
It is clear that larger epidemiological studies of POLH status are needed to evaluate the 
effects of POLH polymorphisms. 
POLl 
DNA polymerase 1 (Pol 1) was discovered in 1999 as a novel homolog of Pol 11 in 
mammals and is encoded by the human POLl gene [49]. In vitro studies with purified 
enzyme indicate error-prone TLS function on almost all substrates examined, perhaps due 
to the still controversial ability of Pol 1 to incorporate incoming nucleotides using 
Hoogsteen base pairing [50,51]. Exhaustive characterization of the error-prone 
replication properties of Pol 1 has lent credibility to the hypothesis that Poll is a candidate 
gene for the Pulmonary adenoma resistance 2 (Par2) locus in mice [52,53,54]. The Par2 
locus was identified in 1996 by chromosomal linkage mapping between BALB/cJ and 
All mouse strains and plays a major role in the relative resistance of BALB mice versus 
the All strain to developing urethane-induced lung adenomas [55]. Wang et al identified 
ten amino acid-substitution polymorphisms between All and BALB mice that produce 
changes in substrate recognition of POll; while the enzyme from both strains is 
functional, the isoform expressed in BALB mice may be more accurate on certain 
undamaged templates [53]. These studies suggest that POll acts to suppress urethane-
induced lung adenomas. It has been hypothesized that this activity is due to the 
augmentation of base excision repair (BER) by POll, because the enzyme has 
5'deoxyribose phosphate (dRP) lyase activity and can partially reconstitute the BER-
deficiency of Pol ~-null cells in vitro [56]. It is possible that after urethane-induced DNA 
damage, which produces 1,N'-ethenoadenine adducts [57] that are primarily repaired by 
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BER [58], Pol t acts in the gap-filling step of lesion repair. If the isoform of Pol t 
expressed in All mice is more likely to add the incorrect G opposite a template T in the 
gap-filling step ofBER, as was found in vitro [53], this could explain the increased 
incidence oflung adenomas in All mice. In support of this hypothesis, nearly all 
urethane-induced adenomas in mice have a CAA 7CGA transition in codon 61 of Kras2 
[52]. In addition, 129-derived mouse strains that carry a SNP in codon 27 of Pob 
resulting in a severely truncated protein [59] display extreme sensitivity to urethane-
induced lung adenomas [54]. Despite reports that splice variants of Pob can exclude 
ex on two [53], which contains the premature stop codon in 129 mice, and that brain 
extracts from 129 mice show Pol t activity in a complex in vitro assay [60], a recent 
report clearly showed that the isoform of Pol t missing exon two is catalytically inactive 
[61]. Thus, 129 mice either express a severely truncated 26 amino acid Pol t protein, or 
an isoform lacking exon two which contains two of the three residues that make up the 
catalytic triad of the active site. In either case, the functional effect is Polz deficiency. 
In the absence of Pol t, it has been hypothesized that another DNA polymerase, 
such as Pol ~, inserts the incorrect base during gap filling in the repair of urethane-
induced DNA damage. However, normal mouse Pol t displays extremely error-prone 
properties during synthesis opposite all four undamaged template bases in vitro [59], 
making it unlikely to prevent mutations during BER in mice that are Pol t-competent. 
Further studies must be completed to determine the tumor suppression mechanism of Pol 
t in mouse lung carcinogenesis. 
A growing body of evidence suggests that Pol t is involved in error-prone TLS of 
UV-induced DNA damage in vivo. The heightened UV mutagenesis ofPollj-null (XP 
11 
variant) human cells has been attributed to TLS by Pol t [62]. Loss of the functional Polz 
gene in dermal cells results in a dramatically reduced UV-induced mutation frequency at 
the Hprt locus in both wild-type and Pol ll-deficient mice (Fig. 1-2). Remarkably, 
however, the decreased UV-induced mutagenesis observed due to loss of the error-prone 
Pol t from Pol ll-deficient mice is associated with increased cancer risk after UV 
exposure(Fig. 1-3) [63]. This result was confirmed and extended by Ohkumo and 
colleagues who showed that Po/(i- mice are more likely to develop aggressive 
mesenchymal tumors after UV than Polz-proficient siblings [64]. These apparently 
contradictory findings speak to the fact that cancer etiology is more complex than the 
point mutations scored by the Hprt assay, and that one cannot use cell biology alone to 
accurately predict cancer risk in a TLS model. Indeed, they suggest a tumor suppressor 
role for Pol t that could be separate from its role as a TLS polymerase prone to induce 
single base-substitution mutations. It is also possible that Pol t is error-free when 
bypassing a minor UV adduct, or that it is involved in error-free BER of the minimal 
oxidative damage induced by UVB used in these studies [65], but more detailed 
experiments must be performed to evaluate these possibilities. 
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Fig. 1-2. Frequency of 6-thioguanine-resistant (TGT) clones as a function of survival after 
UV irradiation. Cells were plated on three ISO-mm-diameter dishes at a density of 104 
cm-2 to determine mutant frequency or at cloning density to determine survival. After 
attachment, plates were irradiated with UV fluences to yield 20-40% survival. The actual 
survival in the mutagenesis experiments was determined by refeeding the survival plates 
at one week and staining with crystal violet after two weeks. Percent survival for each 
UV fluence was corrected for replating and plotted on the x-axis. The corresponding 
mutant frequency at each survival is plotted on the y-axis. Each point represents the mean 
of three independent dishes at the indicated survival, ±1 SD. Mutant frequency at the 
Hprt locus is defined as the number of TGT clones per million clonable cells. Each data 
point represents independent experiments in which 2-4 x 106 surviving cells were 
selected after UV irradiation and an 8- to 9-day expression period. The data have been 
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corrected for cloning efficiency on the day of selection, and the spontaneous background 
mutant frequency (1 x 10-5) has been subtracted. The arrows indicate the reduction in 
mutant frequency when Poll is disrupted in the Pol Tj-deficient background (larger arrow) 
and in the Pol Tj-proficient background (smaller arrow). Reproduced with permission 
from DumstorfC A et al. PNAS 2006;103:18083-18088, Copyright 2006 National 
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Fig. 1-3. UV light-induced skin cancer in mice. Mice were shaved once per week and 
irradiated three times per week with 3.75 kJ/m2 for 20 weeks or until the first skin tumor 
arose. Mice were inspected weekly for the development of skin tumors. All 12 
homozygous Poll1 knockout mice (open diamonds) developed skin tumors by 18 weeks, 
while all 12 Po 111 + Poll + mice (open circles) developed skin tumors by 13 weeks. This 
Polz-dependent decrease in tumor latency is highly significant (p<0.0002). No difference 
was found in the histological analysis of skin tumors among the groups. Reproduced 
with permission from Dumstorf C A et al. PNAS 2006; I 03: 18083-18088, Copyright 
2006 National Academy of Sciences, USA. 
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The role of Pol t in the induction of cancer induced by other carcinogens has not 
been systematically studied to date. It is interesting to note that Newcomb et a/ found 
that Polt-deficient 129 mice are resistant to y-irradiation-induced thymic lymphoma but 
sensitive to methylating agent-induced thymic lymphoma [66]. y-Irradiation induces 
DNA strand breaks and oxidative damage, and Polt is known to protect cells from 
oxidative stress [67]. It is therefore possible that increased cell death after y-irradiation 
protects PO/{I- 129 mice from lymphomagenesis. However, Polt does not affect the 
sensitivity of Pol ~-null cells to methylating agents [68], so the sensitivity of 129 mice to 
thymic lymphoma induced in this way is still unexplained. 
There is no known human disorder involving deficiency for Pol 1. However, Pol t 
is overexpressed in some lung cancer cell lines [69] as well as in primary human gliomas 
[18]. The T706A SNP was found to increase the risk of adenocarcinoma and squamous 
cell carcinoma of the lung in persons <61 years of age [33]. However, this association 
was not confirmed by another independent study [70] and failed to show significance in a 
meta analysis [71]. Another SNP in human POLl, F532S, is associated with prostate 
cancer patients whose tumors display TMPRSS2-ERG fusion with a highly significant 
odds ratio of 4.6 [72]. The protooncogenic transcription factor ERG was identified as the 
most frequently overexpressed gene in human prostate cancers [73], and fusion with the 
androgen-responsive serine protease TMPRSS2 by chromosomal rearrangement was 
found in >90% of ERG-overexpressing cases [74]. Threonine 706 and phenylalanine 
532, the two residues altered by these SNPs in Polt, are located in the noncanonical 
ubiquitin-binding motifs UBM2 and UBMl, respectively [75]. These two 
polymorphisms could therefore affect binding of Pol t to ubiquitylated peNA, which is 
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required for its recruitment to stalled replication forks following DNA damage. In the 
case of prostate cancer, the F532S variant of Pol 1 may promote chromosomal instability 
by causing replication fork stalling and double-strand break (DSB) formation. DSB 
formed in this way could promote cellular transformation by causing chromosomal 
rearrangements that place the proto oncogene ERG under control of the androgen-
responsive promoter elements of TMPRSS2 and lead to ERG-overexpression as is found 
in many prostate cancers [74]. Evidence supports the suppression of skin and lung 
cancers by POll in humans and mice, and new studies suggest that other cancers could be 
affected by this protein, making it a promising candidate for future investigation. This 
dissertation focuses on the role of POll in cell cycle checkpoint regulation and 
carcinogenesis after exposure to UV light. 
POLK 
The fourth member of the V-family is DNA polymerase K. Pol K performs 
faithful TLS of BPDE-induced DNA damage in vitro by inserting de opposite a template 
BPDE-adducted G [76,77,78]. Pol K is required for recovery from a novel BPDE-
induced intra-S phase checkpoint, and the protein relocalizes to stalled replication forks 
after BPDE-induced DNA damage [79,80]. PoIK-1- mouse embryonic fibroblasts (MEFs) 
show persistent S-phase arrest after BPDE exposure, which results in increased DSB 
formation at stalled replication forks and increased toxicity in cells without functional Pol 
K [80]. Avkin and colleagues measured TLS efficiency and fidelity in PoIK-1- MEFs using 
a shuttle vector technique. TLS efficiency on a plasmid containing a site-specific BPDE-
N 2 -dG adduct is reduced nearly threefold in PolK-1- MEFs, and mutagenic TLS is 
increased from 29% to 50% in knockout cells, supporting a role for Pol K in the efficienct 
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and error-free bypass of BPDE DNA damage [81]. siRNA-mediated POLK-knockdown 
also reduces the efficiency ofTLS past BPDE-N2-dG in human U20S cells [82]. This 
body of evidence suggests that Pol K could have an important role in cancers caused by 
bulky chemical carcinogens like BPDE. Pol K has also recently been linked to nucleotide 
excision repair. POIK-1- MEFs have reduced levels ofNER ofUV damage, including 
reduced repair synthesis and removal of 6-4 photoproducts after UV. Both of these 
phenotypes are largely corrected by expressing wild-type Pol K, but not a catalytically 
inactive mutant [83]. Pol K carries out NER repair synthesis and is recruited to sites of 
NER through its interaction with XRCCI and ubiquitylated PCNA [84]. These 
remarkable studies highlight the ability of TLS polymerases to function in multiple 
cellular pathways and the likelihood that POlK plays an important role in preventing DNA 
damage-induced carcinogenesis. While PolK-knockout mice have been generated [85,86] 
and show increased spontaneous mutagenesis in kidney, liver, and lung [87], no cancer 
studies have yet been reported using these models. 
Pol K is overexpressed in ~ 70% of non-small cell lung cancers (NSCLC) 
examined [88], and this overexpression correlates with mutation status of TP53 [69] 
which is itself an indicator of poor prognosis [89]. In addition, POLK promoter activity is 
increased in TP53-/- cells, and p53 protein suppresses POLK promoter activity in vitro. 
These reports suggest that Pol K overexpression in NSCLC could be secondary to loss of 
functional p53, but the correlation between these two events must be investigated to rule 
out an etiological role for Pol K in lung cancer. Much stronger epidemiological evidence 
shows that Pol K is overexpressed in gliomas. Multivariate analysis indicates that Pol K 
overexpression is an independent prognostic factor for the assessment of glioma patient 
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outcomes (Fig. 1-4) [18]. Although the potential role of Pol K in the etiology of brain 
tumors is unclear, Pol K is clearly a candidate for investigation of cancer risk and 
chemoprevention of multiple tumor types. 
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Fig. 1-4, Immunohistochemical analysis of Pol K, Pol t, and Pol 11 expression in primary 
glioma tissues (G) and normal brain tissues (N). Paraffin-embedded tissue microarrays 
comprising 104 primary glioma specimens from WHO grades I-IV were stained for Pol 
K, Pol t, or Pol11. Representative images of PolK, Pol t, and Pol11 expression: Aa, Ab, Ba, 
Bb, Ca, and Cb, normal brain tissue; Ac, Ad, Bc, Bd, Cc, and Cd, pilocytic astrocytoma 
(WHO grade I); Ae, Af, Be, Bf, Ce, and Cf, diffuse astrocytoma (WHO grade II); Ag, 
Ah, Bg, Bh, Cg, and Ch, anaplastic astrocytomas (WHO grade III); Ai, Aj , Bi, Bj , Ci, and 
Cj , glioblastoma multiforme (WHO grade IV); magnification: X100 (Aa, Ac, Ae, Ag, Ai, 
Ba, Bc, Be, Bg, Bi, Ca, Cc, Ce, Cg, and Ci) and X400 (Ab, Ad, Af, Ah, Aj , Bb, Bd, Bf, 
Bh, Bj , Cb, Cd, Cf, Ch, and Cj). Reproduced with permission from Wang et al. NEURO 
ONCOL.2010; 12(7): 679-686; by permission of the Society for Neuro-Oncology. 
Copyright 2010 Society for Neuro-Oncology. 
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POLl; 
The human homolog of yeast DNA Polymerase ~ is required for mutagenesis by 
UV, BPDE, and other carcinogens [14,90]. Pol ~ belongs to the B-family of DNA 
polymerases and contains a large catalytic subunit encoded by the REV3 gene in humans 
[14] along with the much smaller regulatory protein REV7 [91). Early investigations in 
Saccharomyces cerevisiae showed that rev3 mutant strains have reduced rates of 
spontaneous mutation [92], indicating that Pol ~ is involved in the mutagenic processing 
of spontaneous and UV-induced mutations. Studies in mammalian cells indicate Pol ~ 
has a role in both repair of double strand breaks and base substitution mutagenesis, the 
latter likely involving extension of mispaired primer termini after initial TLS by another 
polymerase [93,94]. Pol ~ is the only TLS polymerase required for development, and 
complete Rev3-knockout results in mitotic catastrophe and lethality at mouse embryonic 
day 10.5 [95,96,97). However, conditional Rev3-knockout mice have been generated and 
are viable and fertile. While Rev3-deficiency alone is insufficient to promote cancer 
formation, conditional Rev3 knockout accelerates the spontaneous formation of 
lymphoma in Trp53-1- mice. In humans, REV3 gene expression is reduced by two-fold in 
40 of74 (54%) colon carcinomas compared to matched normal tissue [98]. However, 
normal expression is found in much smaller sample sets of gastric, colon, lung, and renal 
cancers [99] and the gene is not mutated in primary tumors or cell lines from breast and 
colon cancers [91]. The expression levels of REV3 in human cancers, particularly colon 
carcinoma, must be revisited using larger sample sizes to draw firm conclusions about the 
correlation of gene expression and cancer progression. No studies are published 
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investigating the 25 nonsynonymous SNPS in human REV3, but the possibility exists that 
functional changes in human Pol S could alter the risk of cancer formation. 
NUCLEOTIDE EXCISION REPAIR 
Translesion synthesis is a mutagenic process that leaves intact lesions in DNA. 
Most lesions which initiate TLS are removed from the genome by nucleotide excision 
repair (NER), a process by which damaged bases such as CPD are enzymatically 
removed as a part of an oligonucleotide fragment(comprehensive review in [100] (Fig I-
S). NER has two branches; global genomic-NER (GG-NER) describes the repair of 
damage from transcriptionally silent areas of the genome, while transcription-coupled 
NER (TC-NER) is dependent on the stalling of RNA polymerase II. The two branches of 
NER differ in the mode of damage recognition. All lesions recognized by NER cause 
local disturbances in the helical structure of DNA; this disturbance is recognized by the 
XPC:RAD23B complex in GG-NER to initiate binding of the complex to the lesion site 
in the DNA [101,102]. XPC acts to recruit TFIIH, a multi-subunit complex [103,104]. 
The next step in GG-NER is the formation of the preincision complex, which requires 
recruitment of the scaffolding protein XPA, the endonuclease XPG, and the ssDNA-
binding protein RP A [105]. XPD and XPB are A TP-dependent helicases contained in the 
TFIIH complex confer single-strand character on a ~30 nucleotide region surrounding the 
lesion [106]. The damaged lesion is pinpointed during formation of the preincision 
complex, which allows XPG to be positioned and to cleave the damaged DNA stand 3' of 
the lesion. The ERCCI-XPF complex is then recruited to excise the oligonucleotide 
fragment by cleaving the damaged strand 5' of the lesion [107]. Repair synthesis then 
fills the resulting single-strand DNA gap, and this step is performed by one of the 
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replicative B-family polymerases, Pol 8 [108] or Pol £ [109], or by Pol K as previously 
discussed [84]. Finally, the patch is sealed by a DNA ligase [110]. 
TC-NER differs from GG-NER in the manner oflesion recognition, and was 
discovered based on the observation that UV-induced CPD are removed from the highly 
transcribed DHFR gene approximately 50-fold faster than a nearby untranscribed region 
of the genome [111]. Stalling of RNA polymerase II causes recruitment of the SWIISNF 
ATP-dependent chromatin remodeling complex CSB/RAD26 and rewinding of the 
transcription bubble [112]. This promotes dissociation of the RNA polymerase and 
identification of the lesion in the DNA template, at which point RP A, XP A, and TFIIH 
are recruited to the lesion site to form the preincision complex, as in GG-NER. 
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Global Genome Repair 













Fig. 1-5. Nucleotide excision repair (NER). Transcription coupled NER and global 
genomic NER differ in the mechanism of lesion recognition, but share common excision 
and repair synthesis proteins. Illustration kindly provided by Dr. 1. Christopher States, 
University of Louisville. 
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XPA-deficient cells have no residual NER activity [113], and XPA humans and 
mice have dramatically increased risk ofUV-induced skin cancer [35,114]. XPA cells are 
hypermutable due to deficiency in both TC-NER and GG-NER subpathways of excision 
repair. Xpa-I- mice are used in UV carcinogenesis studies described in this dissertation 
due to the advanced time line of cancer development in these animals. 
CELL CYCLE CHECKPOINTS 
Precise regulation of cell cycle progression is critical for maintenance of genomic 
integrity for actively dividing cells. Cell cycle progression was originally proposed to 
have a fixed timeline, but this theory was disproved when y-irradiation caused cell cycle 
arrest proportional to the amount of DNA damage induced [115]. Eukaryotic cells 
display G liS, G21M, intra-S, mitotic spindle, and postreplication checkpoints after 
various types of DNA damage; the G21M and intra-S phase checkpoints are most relevant 
to this dissertation. 
Progression from G2 to M phase is regulated by the cyclin dependent kinase 
CDK1, and DNA damage-induced arrest regulates the activity ofCDKl through a series 
of phosphorylation events (Fig. 1-6). G2-arrest is maintained by the inhibitory 
phosphorylation ofCDKl on Tyr15, catalyzed by the kinase WEEI [116,117]. CDK1 is 
dephosphorylated at Tyr15 and activated to promote G2 -7 M progression by the dual-
specificity phosphatase CDC25. CDC25C is regulated by sequestration in the cytoplasm 
by 14-3-3 proteins. CHK1 kinase-mediated phosphorylation ofSer2160n CDC25C in the 
nucleus promotes binding of 14-3-3 and nuclear export [118,119]. Polo-like kinase 1 
(PLK1) is a master regulator of the G2/M checkpoint. PLK1 phosphorylates cyclin Bat 
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Ser133 and Ser147 and promotes further activation of the CDC2/cyclin B complex to 
promote mitotic entry [120,121]. WEEI kinase is regulated by destabilizing 
phosphorylation by PLKI and CDC2 [122]. MYTl is another kinase responsible for 
inhibitory Tyr 15 and Thr14 phosphorylation of CDC2, and MYTl is 
hyperphosphorylated and deactivated by PLKI. PLKI also phosphorylates CDC25C in 
the nuclear export signal to prevent its nuclear export in a l4-3-3-independent manner 
[123]. 
The intra-S phase checkpoint is a p53-independent mechanism of arresting DNA 
synthesis upon DNA damage. y-irradiation-induced DNA damage activates the sensor 
kinase A TM, which in tum activates the effector kinase CHK2. Activated CHK2 then 
phosphorylates CDC25A at Ser123 to promote the proteasomal degradation ofCDC25A. 
Degradation of CDC25A, the regulatory phosphatase, for the G liS checkpoint leads to 
sustained inhibitory phosphorylation of CD K2 at Tyr 15 and Thr 14 and persistent S-phase 
arrest [124,125]. Translesion synthesis proteins are known to regulate the intra-S phase 
checkpoint. While UV most strongly activates the p53-dependent G liS checkpoint in 
normal cells, XP variant cells show a strong intra-S phase checkpoint [38,39]. While 
new origins of replication fire at expected rates, replication fork progression is blocked at 
sites ofUV-induced DNA damage. The absence ofPollj, the evolutionarily conserved 
TLS polymerase for bypassing UV -induced DNA damage, prevents resolution of stalled 
replication forks and leads to activation of the ATRlCHKl pathway [126]. BPDE also 
induces an intra-S phase checkpoint [79,127], that is dependent upon the V-family Pol K. 
A deficiency in this polymerase results in failure to recover from BPDE-induced S-phase 
arrest and causes double strand breaks, likely due to collapse of stalled replication forks 
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[80]. These studies show that TLS polymerase can directly impact cell cycle checkpoints 
via their role in stabilizing stalled replication forks 
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CONCLUSIONS 
The importance of trans lesion DNA synthesis in preventing human cancer is well 
understood from the example ofXP variant, in which patients lacking the V-family DNA 
polymerase 11 are prone to develop UV -induced skin cancers due to an extremely 
hypermutable phenotype. However, we understand very little about how the other 
polymerases involved in TLS affect human health and cancer risk. Recently developed 
mouse models have so far provided conflicting results; ribozyme-mediated knockdown of 
total Rev 1 and removal ofthe BRCT domain both result in reduced mutagenesis by 
BPDE or UV, respectively. As expected, when Rev} mRNA is knocked down using the 
same ribozyme delivered to the lungs of mice, multiplicity ofB[a]P-induced lung 
adenomas decreases [32]. In contrast, Revl BRCT-null mice develop UV-induced 
squamous cell carcinomas faster than wild-type controls [20]. In a similarly paradoxical 
finding, mice lacking both Pol 11 and POll have decreased UV -induced mutations in their 
dermal fibroblasts and accelerated development of squamous cell carcinoma after UV 
treatment compared to Poll-proficient animals [63]. While it is understood that the 
mutations induced by these polymerases are etiological in many environmentally-induced 
cancers, it is clear from these studies that simply blocking TLS is not sufficient to reduce 
cancer risk, and in fact may cause an acceleration of carcinogenesis. One potential 
explanation for these apparently contradictory findings is that TLS polymerases have 
pleiotropic functions; DNA damage tolerance is the classic role, but they are also 
involved in cell cycle checkpoint regulation [80], NER [84], and somatic hypermutation 
[21]. Data presented in this dissertation indicate that POll is involved in regulating the 
G2/M checkpoint after UV-induced DNA damage. These results suggest a novel role for 
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CELL CYCLE CHECKPOINT REGULATION 
INTRODUCTION 
Translesion synthesis (TLS) is the direct synthesis of DNA across from a 
damaged template and is performed by the Y-family of DNA polymerases [2]. These 
specialized enzymes (PoITj, t, K, and REVI in higher eukaryotes) are recruited to stalled 
replication forks due to blockage of the replicative DNA polymerases, POID and Pole, at 
sites of DNA damage. Mammalian cells use TLS instead of more accurate damage 
bypass mechanisms as much as 50% of the time to bypass replication-blocking lesions 
[10,11,12]. The frequency ofTLS combined with its highly mutagenic potential make it 
a critical target of study for cancer chemoprevention. PolTj catalyzes accurate TLS of the 
most common CPD [41,42] and is defective in xeroderma pigmentosum (XP) variant 
syndrome [43,128]. XP variant patients have extremely high risk ofUV-induced skin 
cancer because their cells are extremely hypermutable upon UV exposure [40]. Pol t 
catalyzes inaccurate, error-prone TLS ofUV-induced DNA damage [129] and is at least 
partially responsible for the high frequency ofUV-induced mutations in XP variant cells 
[62,130]. We previously found that mouse cells lacking functional Poh have reduced 
mutation frequencies after UV irradiation, but the loss of this error-prone DNA 
polymerase accelerates tumorigenesis in PolTj-deficient mice [63]. Accelerated 
tumorigenesis in 
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Polr( Pol/- mice has been confirmed [64] and suggests that Pol t could participate in 
UV -induced carcinogenesis outside of its role in TLS. 
In addition to participation in DNA synthesis, V-family polymerases are known to 
regulate cell cycle progression. The first known example was the pronounced intra-S 
phase arrest observed in XP variant cells after UV irradiation [38,39]. Cells lacking Poll] 
fire new origins of replication, but elongation of nascent strands is blocked due to 
unresolved replication fork stalling. POlK has also been shown to regulate a distinct intra-
S phase checkpoint. After treatment with benzo[a]pyrene dihydrodiol epoxide (BPDE), 
PoIK-/- MEFs fail to complete S phase at the rate of wild-type cells and display elevated 
activation of ATM and Chk1 [80]. Other reports have shown that S. cerevisiae Rev1 
protein levels are ~50-fold higher in G2/M phase than in G 1 [131], and that disruption of 
the BRCT domain ofRev1 in mouse cells causes G2 arrest after UV treatment [30]. 
These studies together suggest that V-family DNA polymerases can affect cell cycle 
checkpoints after treatment with genotoxic agents. The experiments in this chapter were 
designed to address the hypothesis that Pol t regulates cell cycle progression after UV-
induced DNA damage. 
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Materials and Methods 
Cells and cell culture 
Primary murine fibroblasts from Polr( and Pol/- mice were a generous gift from Raju 
Kucherlapati (Harvard University) and were prepared as described previously [63] with 
slight modifications. A piece of ear tissue was rinsed thoroughly in ethanol, then sterile 
PBS, then finely minced in a 10 cm cell culture dish using two scalpels. The minced 
tissue was allowed to sit for 10 minutes in a laminar flow hood with the dish lid cracked 
for ~ 15 min to allow the tissue to adhere to the dish. Media was then gently added to the 
dish to cover the surface of the tissue. Media consisted ofMEM-a (Cambrex Bioscience, 
Walkersville, MD) supplemented with 10% FBS (HyClone, Logan, UT), 2 mM 
glutamine, nonessential amino acids (Mediatech, Herndon, VA), penicillin (100 
units/ml), and streptomycin (100 g/ml). Minced tissue was placed incubated for up to 
three weeks under normoxic conditions at 37°C / 5% CO2 /21 % O2 and refed weekly. 
Once cells reached confluence, tissue pieces were aspirated off and cells were designated 
"passage zero" and split to a 15 cm dish. After passage zero was reached, all primary 
mouse cells were incubated under hypoxic conditions (5% CO2 /2% O2 ) based on a 
previous report that these cells have increased population doublings and time to 
senescence under hypoxia [132]. For UV treatments, UV 254nm flux was measured using a 
radiometer (model IL 1700; International Light, Peabody,MA). The average fluence was 
~0.5 J/m2/s. Media was aspirated and cells were washed twice with PBS exposure to 4, 
8, or 16 J/m2. SV40-transformed human fibroblasts (GM0637) were cultured in DMEM 
(Cambrex Bioscience, Walkersville, MD) supplemented with 10% FBS (HyClone, 
Logan, UT), 2 mM glutamine, penicillin (100 units/ml), and streptomycin (100 giml). 
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mRNA expression 
Total mRNA was isolated from cell culture plates on ice using the miRNeasy kit (Qiagen, 
Valencia, CA), amplified, and resultant cDNA was transcribed using the GeneChip® IVT 
Labeling Kit for hybridization on Affymetrix MOE 430_2.0 arrays using a GeneChip® 
Scanner 3000 7G. A two-way ANOVA including interaction was used to detect 
transcripts with significant interactions between cell line and treatment. An overall F-test 
was used to determine which transcripts had at least one significant effect using the SAS 
software package. An FDR cut-off of 0.1 was used for multiple testing correction, 
followed by a cut-off for interaction p-value of 0.05 to produce a list of transcripts with a 
statistically significant interaction effect. This interaction list was filtered to include only 
transcripts with relative fold changes of> 1.5 or <-1.5 in either cell line. Statistical 
analyses were performed in collaboration with the Bioinformatics, Biostatistics, and 
Computational Biology core facility at the Center for Environmental Genomics and 
Integrated Biology at UoiL. 
microRNA expression 
cDNA was generated and labeled, hybridized to microarrays, and scanned by LC 
Sciences (Dallas, TX). Total RNA was isolated using the miRNeasy kit (Qiagen, 
Valencia, CA) and enriched for transcripts <300nt using size fractionation after which 
these transcripts were 3' extended with poly(A) polymerase and fluorescently labeled 
with either Cy3 or Cy5. Hybridization of one Cy3- and one Cy5-labeled sample per chip 
was followed by detection and quantification of fluorescence and as the Cy3/Cy5 ratio. 
Microarrays were designed by LC Sciences and included redundant probes to detect all 
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miRNA transcripts listed in Sanger miRBase 10.1. Data were analyzed by background 
subtraction and LOWESS normalization, and a p-value cut-off of 0.05 was applied for 
the t-test. 
RT-qPCR 
Confirmation ofmRNA and microRNA expression was performed by amplifying target 
transcripts using specific primers and probes and a 7900HT Fast Real-Time PCR System 
from Applied Biosystems (Foster City, CA). The ~~CT method was used to measure 
target mRNA or microRNA expression relative to GAPDH or snoRNA202, respectively. 
microRNA target prediction: 
Individual microRNAs determined to have significant expression changes after UV 
treatment (p<0.05 by a t-test) were used as search terms for the miRanda microRNA 
target prediction algorithm [133,134]. The list of predicted microRNA targets for each 
genotype were intersected with the list ofUV-responsive mRNAs to produce a list of 
filtered microRNA targets for each genotype. 
Global pathway analysis 
Three lists of mRNAs were analyzed using Ingenuity Pathway Analysis (Ingenuity 
systems): interaction mRNA, Polr( Poll +/+ filtered microRNA targets, and Polrt Pol,-/-
filtered microRNA targets. 
Immunoblots 
For immunoblots, celllysates were prepared from trypsinized cell pellets with 10 mM tris 
base pH 7.4,1 mM EDTA, 0.1% SDS, 180 J.lglml phenylmethanesulfonylfluoride). 
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Twenty /lg whole cell lysate was separated on a 4-15% SDS-PAGE gel and transferred to 
a PVDF membrane via electroblot using Towbin's transfer buffer (25 mM tri~ base pH 
8.3,192 mM glycine, 20% methanol, 0.02% sodium dodecyl sulfate), and analyzed with 
the following antibodies: Weel (Millipore, 1 :500), cyclin Bl (BD Pharmingen, 1: lOOO), 
Cdkl (Millipore I: 1000), cyclin E (Abeam, 1 :500), phospho-histone H3 (Cell Signal, 
1: 1000), and ~-actin (Sigma, 1: 10,000). All antibodies were diluted in 5% nonfat dry 
milk and incubated overnight at 4°C. 
Cell cycle analysis 
Cells were pulse labeled for 30 min with 10 /lM BrdU (BD Pharmingen, San Diego, CA), 
washed twice with PBS, and immediately UV irradiated. At 0,6, 12, 18,24, and 30 
hours after UV, cells were trypsinized and collected for F ACS analysis. Samples were 
double-stained for BrdU and 7 -aminoactinomycin D (7 AAD) using the FITC BrdU Flow 
Kit (BD Pharmingen, San Diego, CA) following the manufacturer's instructions. F ACS 
analysis was performed on a F ACScan flow cytometer (BD Biosciences, San Jose, CA). 
Results were analyzed using FlowJo software. 
Direct nuclear counting 
Asynchronous cells were plated at 104 / cm2 and stained with giemsa the following day. 
Stained cells were analyzed under 40X magnification. Two hundred cells per well were 
counted for each genotype with three wells in total counted per experiment per genotype. 
Three independent experiments were performed and results were analyzed using a single 
factor ANOV A. Individual comparisons were made using the student's t-test. 
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RESULTS 
Polymerase iota deficiency alters the DNA damage response after UV treatment at the 
transcriptional level 
To detennine the effect of Poll-deficiency on the UV DNA damage response, 
primary ear fibroblasts from Polr( Poll +/+ and Polr( Pol,-/- mice were irradiated with 4 
J/m2 UV, a dose which results in -30% survival [63]. Total RNA was harvested 24 hours 
later and global microarrays were perfonned to analyze mRNA and micro RNA 
expression profiles. There were 6,397 and 5,207 UV -responsive mRNAs in Polr( 
Poll +/+ and Polr( Pol(/- cells, respectively. These transcripts all had fold changes> 1.5 
or <-1.5 with p < 0.05 and q < 0.1. To statistically differentiate between these large lists 
ofUV-responsive mRNAs and identify the transcriptional effect of Poll-knockout on the 
UV DNA damage response, the interaction tenn was included in the two-way ANOV A 
analysis ofUV treatment and genotype effect. In this statistical test, a significant 
interaction tenn indicates that the UV -induced fold change of a particular mRNA was 
different between the two cells trains. This analysis identified 484 mRNAs, tenned the 
"Interaction mRNA" (Fig. 2-1), with a significant interaction between Polr( Poll+/+ and 
Polr( Pol/- cells after UV treatment (p < 0.05, q < 0.1, fold change> l.5 or <-l.5). 
UV-responsive miRNAs are shown in Fig. 2-2. Nine microRNAs were identified 
in Pob( Poll +/+ cells and 11 microRNAs in Polr/ Pol,-/- cells with significant fold 
changes after UV treatment (p < 0.05). Remarkably, the lists ofUV-responsive 
microRNAs were mutually exclusive. To confinn the microarray results, two mRNAs 
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Fig. 2-1. UV-induced mRNA expression changes in Polr/ Poll+1+ and Polr/ PoH1- cells. 
Treatment with ultraviolet radiation altered expression of 6,397 genes in Polr/ Poll +1+ 
cells and 5,207 genes in Polr/ Pol(l- cells (p < 0.05, q < 0.1, and -1.5 > fold change > 
1.5 in either genotype). A list of 484 transcripts showed a significant interaction effect 
with p < 0.05 and q < 0.1. Results are from three replicate dishes from a single biological 
experiment. The color key indicates normalized signal intensity values. 
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Fig. 2-2. UV - induced microRNA expression changes in Polr{ Polt+l+ and Polr{ Pol ( 1-
cells. A t-test identified 9 microRNA in Polr/ Poh +/+ cells and 11 microRNA in Polr( 
Pol/- cells that showed significantly altered expression after UV treatment (p < 0.05). 
The two lists were mutually exclusive. Results are from three replicate dishes from a 
single biological experiment. 
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and two microRNAs were chosen at random from the lists of significantly altered 
transcripts for RT-qPCR confirmation. As shown in Figure 2-3, micro array results for 
mRNA and microRNA were reproducible with the exception of Ptprv increased in Polr/ 
Polz+/+ cells which could not be confirmed. We also found using RT-qPCR that miR-214 
was slightly but significantly decreased in Polr/ Pol/- cells, which was not found using 
the microarray platform. 
Bioinformatics analysis indicates that Polz-deficiency alters the PLK pathway for mitotic 
entry and exit 
In order to combine mRNA and microRNA expression data, a bioinformatics 
approach was used to identify the cellular pathway(s) affected by Pair-deficiency after 
UV treatment. Figure 2-4 shows a schematic representation of the analyses performed. 
The miRanda microRNA target prediction algorithm was used to computationally predict 
mRNA targets of the 9 and 11 UV -responsive microRNAs in Polr/ Pair +/+ and Polr/ 
Polr-/- cells, respectively. This analysis yielded 8,519 predicted microRNA targets in 
Pob(- Polr +/+ cells and 6,360 predicted targets in Polr( Po//- cells. To reduce the total 
size and increase the biological relevance of the predicted microRNA targets dataset, the 
list of predicted microRNA targets for each genotype was then intersected with the list of 
UV -responsive mRNAs identified in the two-way ANOV A. In Polr( Polz +/+ cells, this 
final filtered microRNA targets list contained 1,529 mRNAs, while 1,339 filtered 
microRNA targets remained in Pob(- Pol/- cells. 
Three lists of mRNAs were analyzed for global pathway enrichment using 
Ingenuity Pathway Analysis (lPA). The 484 interaction mRNAs, 1,529 filtered Pob( 
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Fig. 2-3. Confirmation of micro arrays by RT-qPCR. UV-induced gene expression 
changes were validated using R T -qPCR for four transcripts. A significant decrease was 
measured for miR-214 in Polr( Pol/- cells using qRT-PCR that was not identified using 
the microarray platform. Results are from four replicates from two independent 
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Fig. 2-4. Combining mRNA and microRNA expression datasets, Venn diagram 
representing biostastistical and bioinformatics analyses of mRNA and microRNA 
datasets, Shaded ovals represent experimentally obtained datasets, unshaded ovals 
represent computationally determined datasets , A two-way ANOV A featuring the 
interaction term was used to generate the interaction mRNA list (see Figure 1), The 
miRanda target prediction algorithm was used to predict all mRNA targets ofUV-
responsive miRNA's in both cell strains, To reduce the size and increase the biological 
relevance of the microRNA targets list, the predicted targets list was intersected with the 
UV effect t-test list. The resulting filtered microRNA targets lists totaled 1,529 in Polr( 
Pol/ 1+ cells and 1,339 in Polr( Pol(l- cells, 
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Pob +/+ microRNA targets, and 1,339 filtered Polr( Pol(/- microRNA targets lists were 
all analyzed using IPA and the results are presented in Fig. 2-5. The only canonical 
pathway that was significantly enriched in all three lists was the PLK signaling pathway 
for mitotic entry and exit. Of the 62 molecules that IP A lists in the pathway, the 
interaction mRNA list contained 12/62 (p = 1.17E-9), the Poi1'( Poll +/+ filtered 
microRNA targets list contained 10/62 (p = 1.48E-2), and the Polr( Pol(/- filtered 
microRNA targets list contained 10/62 (p = 2.19E-3). 
To more closely examine gene expression patterns in the PLK signaling pathway 
for mitotic entry and exit, all genes listed in this pathway by IP A were downloaded and 
analyzed in our mRNA dataset for expression patterns. Of the 70 genes listed by IPA in 
the pathway, 31 were significantly altered in both Polr( Poh +/+ and Poll'/" Pol(/- cells (p 
< 0.05, q < 0.1, and -1.5 > fold change> 1.5); the lists were not identical. Fig. 2-6 shows 
the 10g2(fold change) ratios for all of the 37 genes that were altered in either genotype. 
Twenty-seven of 37 (73 %) genes were increased in one or both genotypes; of these, 23 
(85%) showed greater increase in Pol'!-/- Pob +/+ cells. 
Loss of POll relieves a strong mitotic checkpoint in Pol'!-/- cells after UV 
treatment. 
In order to validate the bioinformatics analysis indicating altered mitotic 
checkpoint activity with Pob-deficiency, cells were treated with 4 J/m2 UV and analyzed 
for protein expression at 24 hours by western blot. Fig. 2-7 shows that in Pol'!-/- Poh +/+ 
cells, UV caused a modest increase in the G21M marker cyclin B 1. In contrast, cyclin B 1 
levels were reduced after UV in Pol'!-/- Pol/- cells. The kinase WEEI was stable at 24 
42 





















Cytol<lneSlslGl 0--- Anaphase 0-- Melaphase 
TrarSlllOn & MitotIC EXit 
Fig. 2-5. Polo-like kinase signaling pathway is enriched in gene lists analyzed. The 
interaction mRNA list, filtered Polr/ Poll +1+ microRNA targets, and filtered 
Polrt-I- Pol(l- microRNA targets were analyzed using Ingenuity Pathway Analysis for 
global pathway enrichment. Polo-like kinase signaling for mitotic entry and exit was the 
only pathway that was enriched and shared among all three lists. Twelve of the 62 
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molecules in the pathway were present on the interaction mRNA list (p= 1.17E-09), along 
with 10 of 62 molecules on the filtered Polr( Polr +1+ microRNA targets list (p= 1.48E-
02), and 10 of 62 molecules on the filtered Pob( Po/(I- microRNA Targets (p= 2.19E-
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Fig. 2-6. mRNA expression changes of PLK signaling pathway members 24 hours after 
UV. Cells were treated as in Fig 2-1. Thirty-seven of 70 genes in the canonical PLK 
signaling pathway for G21M checkpoint regulation were significantly altered (p < 0.05, q 
< 0.1, and fold change > 11.51 in either genotype). Where the blue or red histogram bar is 
omitted for a gene, that gene was not significantly altered in the respective phenotype. 
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Fig. 2-7. Alterations in G21M checkpoint pathway proteins after UV. Twenty four hours 
after treatment with 4 J/m2 UVC, Polr( Poll +/+ cells displayed a nearly two-fold increase 
in cyclin Bl (quantification shown on right). This protein was reduced by a factor of two 
in Polr( Pol(/- double knockout cells at the same time point. WEEl levels were stable in 
Poll'/" Poll +/+ cells but modestly reduced in Poll'/" Pol(/- cells. Levels of CDKl were 
essentially unchanged in both genotypes after UV treatment. Densitometric quantitation 
shown on the right. Results are from a single experiment. 
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hours in Polrt Poll +/T cells but was reduced ~4-fold in Polr( Pol/- cells. CDKI levels 
were unchanged in both genotypes examined. 
To expand the scope of our analysis, cell cycle markers for G21M and G liS arrest 
were analyzed by western blot in all four genotypes. Fig. 2-8 shows that in Polr( Poll +1+ 
cells, UV caused a strong increase in the mitotic marker histone H3 phospho-Serl 0 
(phospho-H3). In contrast, phospho-H3 levels were reduced after UV in Polr( Pol(l-
cells. Levels of phospho-H3 were unchanged in wild type and Po 117 +1+ POl(l- cells. 
Cyclin E, which is expressed at the G liS transition, was strongly reduced after UV in 
wild type and Pol17-I - POl/l+ cells, while Pol17-I - Pol/- showed a strong increase in cyclin 
E levels. Po 117 +1+ Pol(l- cells showed no change in cyclin E at the UV dose used. 
Figure 2-9 shows bivariate F ACS analysis of cell cycle progression in all four 
genotypes after bromodeoxyuridine BrdU labeling and treatment with equitoxic UV 
doses. All cells were pulse labeled with BrdU for 30 minutes to label actively the 
replicating population. Immediately after pulse labeling, cells were UV treated. Wild 
type and Po 117 +1+ POl(l- cells were treated with 8 Jlm2 while Pol17-I- Poll +1+ and Pol17 -1-
Pol/- cells were treated with 4 Jlm2, doses that result in ~37% clonogenic survival [63]. 
To examine the behavior of cells in S phase at the time ofUV treatment, the BrdU(+) 
population was gated and analyzed for cell cycle progression. After 18 hours, ~20% of 
BrdU (+) wild-type cells had completed S, G2, and M phases and were arrested in G I 
phase. In contrast, only ~ I 0% of BrdU( +) Pol17 +1+ Pol/- cells completed the first 
division at 18 hrs, and these numbers were unchanged at 30 hours. Both wild type and 
Po 117 +1+ Pol(l- cells displayed functional G liS checkpoints as indicated by the absence of 
cells entering S phase after UV treatment. In Pol17-I- Poll +1+ cells, the BrdU(+) population 
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showed delayed S-phase progression; the G 1 population was 6% at 18 hours and 12% at 
30 hours. BrdU( -) Pob( Poil +1+ cells did not arrest at the G liS border but progressed 
into a very slow S phase and accumulated in G2/M. BrdU( -) cells in G 1 phase were 
31 %, 18%, and 13% of total cells at 0, 18, and 30 hours, respectively. BrdU( +) Polr( 
Pol/- cells were 7% G 1 at 18 hours and 2% G 1 at 30 hours. Double knockout cells 
showed an increase in the number of polyploid cells which peaked at 18 hours and was 
reduced at 30 hours. Accumulation of polyploid cells was most pronounced in Polr( 
Pol,-I- cells, reaching 40% of total cells at 18 hours, versus ~ 20% in Pob(- Poll +1+ and 
~IO% in wild type. 
To further investigate the apparent increased ploidy of Pol/- cells even before 
UV treatment, all four genotypes of cells were stained with giemsa during asynchronous 
exponential growth and nuclei were counted. The percentage ofbinucleated cells is 
shown in Fig. 2-10. Loss of POll, both from the wild type and Polr( backgrounds, 
resulted in a strong and significant increase in the number ofbinucleated cells. The 
percentages ofbinucleated cells were 1.1 %, 5.6%, 2.0%, and 4.9% in wild type, Pol,-I-, 
Polr(, and double knockout cells, respectively. The difference between wild type and 
Polr( was also statistically significant, indicating that loss of Poll] also causes a slight 
increase in the number ofbinucleated cells. We also examined the percentage of 
binucleated cells in SV40-transformed human diploid fibroblasts (GM0637). The 
GM0637 cell line displayed a low level ofbinucleated cells, two-fold lower that Polr( 
cells and approximately five-fold lower than Po/z-I- and double knockout murine cells. 
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Fig. 2-8. UV -induced accumulation of mitotic markers is reversed by Polz-knockout. 
Twenty four hours after treatment with 4 J/m2 uve, Polr( Polz +/ + cells showed 
accumulation of phospho-serine 10 histone H3 (phospho-H3 , quantification on right). 
This marker was reduced more than two-fold in Polr( Pol/- double knockout cells at the 
same time point, but remained essentially unchanged in wild-type and Pol1J +/+ Pol(/-
cells. The G liS marker cyelin E was reduced in wild type and Pol1J -/-Polz +/+ cells, while 
Pol1J-/- Pol/- cells show increased cyelin E levels 24 hours after UV treatment. No 
change in cyelin E was observed in Pol1J +/ + Poh-/- cells. 
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Fig. 2-9. Pail-deficient cells display polyploidy after UV treatment. Wild type, Pair/" 
Poll +1+, Pol1J +1+ Pol/-, and Pol1J-1- Pol( l- fibroblasts were pulse labeled with BrdU for 30 
minutes immediately before UV treatment. Cells were irradiated with equitoxic UV 
so 
doses (811m2 for wild type and Pol1J +1+ Pol/-; 411m2 for Pol1J-I- Poll +1+, Pol1J-I- Pol(I-) and 
collected at the indicated time points for BrdUI7 AAD multiparametric F ACS analysis. 
All cells showed active DNA synthesis of haploid populations as well as of polyploid 
populations (>4n DNA content). After 18 hours, ~20% of BrdU(+) wild-type cells had 
completed S, G2, and M phases and were arrested in G 1 phase. Only ~ 10% of BrdU( +) 
Pol1J +1+ Poll -1- cells completed the first division at 18 hrs, and these numbers were 
unchanged at 30 hours. BrdU(+) Pol1J-I- Poll+l+ cells showed delayed S-phase 
progression; the Gl population was 6% at 18 hours and 12% at 30 hours. BrdU(+) Pol1J-
1- Pol(l- cells were 7% G 1 at 18 hours and 2% G 1 at 30 hours. Double knockout cells 
showed an increase in the number of polyploid cells which peaked at 18 hours and was 
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Fig. 2-10. Poll-deficient cells display a failure in cytokinesis. Primary mouse fibroblasts 
(wild type, Pol/-, Polr/, double knockout) and SV40-transformed human fibroblasts 
(GM0637) were trypsinized during asynchronous growth and replated at 104 cm-2. The 
following day the cells were stained with giemsa and scored on the basis mono- or 
binucleated status. Averages represent three independent experiments . Histogram bars 
with different letters are significantly different (p<0.05). Error bars, SEM. 
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Discussion 
Despite the fact that multiple reports have characterized Polt as a mutagenic TLS 
polymerase in the bypass ofUV-induced DNA damage [62,63,129], Poll-deficiency has 
been found by two independent groups to decrease the latency ofUV-induced 
carcinogenesis in PollJ-1- mice [63,64]. These remarkable findings suggest that Pob could 
playa novel role in the cellular response to UV -induced DNA damage, and to investigate 
this possibility gene expression changes were examined after UV irradiation in PollJ-1-
Poll +1+ and PollJ-1- Pol/- primary murine ear fibroblasts. UV treatment caused significant 
expression changes of thousands of mRNAs in both genotypes, and pathway analysis 
indicated that these genes are in expected pathways including p53 and apoptotic 
signaling. To more specifically identify the effect of Pob-deficiency, the two-way 
ANOV A used to analyze the mRNA expression data included the interaction term. This 
statistical test was chosen to parse out the common effects ofUV treatment on both 
genotypes in order to identify the ways in which each cell type responds differently to 
UV treatment. The 484 mRNAs with a significant interaction term (the "Interaction 
mRNA") represent the mRNA expression signature of Poll and can be exploited to 
determine which cellular pathways are perturbed after UV treatment by the loss of Pob. 
UV irradiation was also found to affect microRNA expression, and this was also 
directly impacted by Poll-deficiency. Nine and 11 microRNAs were identified in PollJ-1-
Pob +1+ and PollJ-1- Pol/- cells, respectively, as having significant UV -induced changes. 
These two lists of microRNAs were mutually exclusive, indicating a complete divergence 
of the microRNA response to UV-induced DNA damage concomitant with Poll-
deficiency. UV-responsive microRNA have been identified in mammalian cells [135] 
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and linked to the DNA damage response [136]. However, our list ofUV-responsive 
microRNA shows little overlap with previously published reports. Since the cells used in 
this study are derived from nonisogenic mice as described [63] (Polr( Pob +/+ = C58Bl/6; 
Pob(- Po/(/- = hybrid C57B1I6 X 129 X B6 background from an F2 generation 
backcross), we chose to use high stringency statistical cutoffs and multiple methods of 
analysis for the expression data. The nonisogenic nature of the cell strains used does 
raise the possibility that the gene expression results we obtained are actually attributable 
to strain differences rather than to loss of Pol 1. It is for this reason we used strict 
statistical cutoffs followed by biological validation of the microarray results. 
Fig. 2-4 illustrates how mRNA and microRNA expression datasets were analyzed 
using statistical and bioinformatics tools to formulate lists of mRNAs that represent the 
"signature" of Poll in the UV DNA damage response. These lists ofmRNAs can then be 
analyzed for pathway enrichment to identify novel candidate pathways modulated by Poll 
after UV. As described, the Interaction mRNA list was derived directly from mRNA 
microarray data using a two-way ANOV A. The interaction term was utilized in this 
ANOVA to remove the common gene expression patterns ofUV-response between the 
genotypes. In order to have a significant interaction term, a particular mRNA must show 
different fold changes after UV between the two genotypes; thus, the interaction test is 
one way to distinguish unique gene expression patterns due to the loss of Poll. To 
analyze the microRNA expression data for pathway enrichment, the miRanda target 
prediction algorithm was used to generate putative mRNA target lists for the UV-
responsive microRNAs from each genotype [133,134]. Target predictions from miRanda 
are based on partial or complete complementarity of the microRNA with the 3' UTR of 
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the target mRNA. Importantly, because of the computational nature of the target 
prediction method used, several hundred mRNAs were returned as putative targets of 
each UV -responsive microRNA. This generated very large lists of predicted microRNA 
targets which were expected to contain a high percentage of false positives due to 
inaccurate algorithm predictions, estimated to be as high as 34% [133]. For each 
genotype, the list of predicted microRNA targets was intersected with the list ofUV-
responsive mRNAs to generate the list of "Filtered microRNA Targets." This method of 
filtering the predicted microRNA targets list was used to reduce list size and eliminate 
false positives. All mRNAs included on the final list of Filtered microRNA Targets in 
each genotype met two criteria; first, each mRNA was predicted to be the target of at 
least one UV-responsive microRNA from that genotype, and second, each mRNA was 
itself significantly altered by UV treatment. This final filtering step reduced by ~5-fold 
the number of microRNA targets for each genotype to 1,529 in Polr/ Polz +/+ cells and 
1,339 in Pob( Pol(/- cells. 
Ingenuity Pathway Analysis (IPA) was used to analyze three lists ofmRNAs: 
Interaction mRNA, Filtered Pob( Polz +/+ microRNA Targets, and Filtered Pob( Pol/-
microRNA Targets. These three lists were taken to represent the signature of Poh in the 
UV DNA damage response, and global pathway analysis revealed the enrichment of only 
one canonical pathway shared among the three datasets. The PLK signaling pathway for 
mitotic entry and exit was significantly enriched in all three mRNA lists analyzed, 
indicating that deficiency in Poh alters cellular responses to UV damage through this 
pathway. 
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To validate the dysregulation of the G2/M checkpoint after Polz loss, cell cycle 
markers were analyzed by immunoblotting. Accumulation ofphospho-H3 and cyclin BI 
24 hours after 4 J/m2 UV indicates that Pob( Polz +/+ cells accumulate in G21M in 
response to UV -induced DNA damage (Fig. 2-7 and 2-8). Apparent activation of this 
checkpoint coincides with a reduction in levels of the G liS marker, cyclin E, as expected. 
The UV-induced accumulation of mitotic markers was reversed in Polr( Pol/- cells, 
providing evidence that expression ofPoh is required for activation of the G21M 
checkpoint seen in Pob( Polr +/+ cells. Cyclin E expression was increased in double 
knockouts 24 hours after treatment, indicating that cells accumulated at the G liS 
boundary. While WEEI levels were stable in Pob( Pol//+ cells, double knockouts 
showed a strong reduction in WEEI after UV treatment. WEEI phosphorylates and 
inactivates CDKI and is a target of PLKI for phosphorylation and subsequent 
degradation. Reduced levels of WEE I in Polr( Pol(/- cells could indicate increased 
PLKI activity, supporting our finding that the PLKI pathway is dysregulated by Poh 
deficiency. Cyclin E levels were reduced after UV in wild type cells, but stable in 
Po 117 +/+ Polz -/- cells. This change in the response of the G 1 IS marker could be explained 
if Po 117 +/+ Po/(/- underwent endoreduplication and did not divide in order to arrest at 
G liS, as our hypothesis would predict. 
To specifically address cell cycle kinetic changes after UV treatment, we 
examined 7 AAD staining of BrdU-Iabeled cells. In order to label the S phase popUlation 
of all four genotypes immediately before UV treatment, all cells were incubated with 
BrdU for 30 minutes and then treated with equitoxic UV doses (Fig. 2-9). This 
experimental design allows one to gate the BrdU (+) population of cells, those that were 
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in S phase immediately before UV treatment, and follow that population over time to 
examine Sand G2/M exit. Conversely, one can also follow the BrdU(-) population to 
examine rates of entry into S phase after UV. All four genotypes displayed appreciable 
replication of polyploid cells, indicating the presence of a stable population of cells with 
DNA content >4n. BrdU(+)PollJ +1+ Pol/- cells exited mitosis more slowly than wild type 
cells; at 18 hours only 10% of PollJ +1+ Pol(l- cells had completed the first cell cycle 
compared to 20% of wild type cells. Both genotypes displayed a functional G liS 
checkpoint as indicated by the lack of BrdU( -) G 1 cell migration into S phase. The 
finding that Poh-deficiency causes G2/M accumulation in wild-type cells conflicts with 
our previous findings that loss of Poh causes alleviation of the mitotic checkpoint in 
PollJ-1- cells (Fig. 2-9). 
There was significant intra-S phase arrest in PollJ-1- Poh +1+ cells as expected; 
BrdU(+) G 1 peaked at 12% 30 hours after UV treatment. In addition, these cells did not 
arrest at G liS but instead proceeded into a very slow S phase and arrested in the G2/M 
compartment. BrdU(-) PO!IJ-1-Pol/1+ cells decreased from 31 % to 13% of total cells over 
30 hours, indicating a mitotic block which prevented division of these BrdU(-) cells. 
Strong intra-S phase arrest in this genotype was expected [38,39], but the accumulation 
of cells in the G21M compartment at this late time point is a novel finding to our 
knowledge. BrdU( -) PollJ-1-Pol(l- cells displayed a normal G liS checkpoint and did not 
proceed en masse into S phase as the PollJ-1- Po!r+I+ cells had done, indicating that loss of 
both polymerases reactivates the G 1 IS checkpoint. BrdU (+) PollJ -1- Poh -1- cells did not 
divide and return to G 1, but instead underwent endoreduplication. Levels of polyploid 
cells were highest in the double knockouts, and peaked at 40% 18 hours after UV 
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treatment. This finding supports our hypothesis that POll modulates the mitotic 
checkpoint and our previous data that loss of Polz relieves a mitotic checkpoint. 
Our F ACS analysis indicated that a mitotic checkpoint was not activated in Pol/-
cells, allowing them to complete mitosis without dividing and enter a tetraploid state. To 
directly support this hypothesis, we stained asynchronous cultures of cells with giemsa 
and counted mono- and binucleated cells (Fig. 2-10). We found that loss of POll 
increased the percentage ofbinucleated cells by more than two fold. These data support 
our hypothesis that Pol 1 is involved in activation of the mitotic checkpoint, and in its 
absence checkpoint failure leads to the accumulation of endoreduplicated cells. We did 
not a slight but significant increase in the percentage ofbinucleated cells in the Polr( 
genotype. We did not find evidence of increased tetraploidy in Poll)-deficient cells via 
F ACS analysis; nevertheless, direct analysis of the nuclei indicates that Poll) could also 
playa role in regulating the mitotic checkpoint 
The phenotype of increased tetraploidy we observed in Pol/- mouse fibroblasts is 
relevant to human cells, particularly to transformation by simian virus 40. Typically, 
human cells are not permissive of a tetraploid state; anything that induces tetraploidy 
causes death of the cell population via a p53-dependent postmitotic checkpoint [137]. 
However, SV40 infection blocks the activity ofp53 and promotes the gradual 
accumulation of a tetraploid population very similar to that seen in Poll-deficient cells 
[138]. This is an important finding as it indicates that POll deficiency could be an 
unidentified human health concern. 
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Results presented in this chapter support the hypothesis that Pol 1 regulates the 
mitotic checkpoint, though the exact nature of the regulation appears to depend upon the 
cells' ability to tolerate UV-induced DNA damage. Our gene expression analyses were 
done using Polr/ cells, which lack the major TLS polymerase for accurate bypass ofUV 
damage and rely on Poll to complete mutagenic TLS and, in theory, prevent DSB and 
genetic instability. Our results indicated that loss of Poll promotes endoreduplication, 
allowing mitotic completion and blocking cytokinesis. This finding was supported by 
cell cycle kinetics, which showed that Polr( Polz +/+ cells in S phase at the time of UV 
treatment slowly complete Sand G2 and divide. Loss of Poll causes cells to bypass 
division and endoreduplicate, indicating they have bypassed the spindle assembly 
checkpoint in M phase and entered a tetraploid state. In wild type cells replicating DNA 
during UV treatment, loss of Polz causes a reduced rate of division after UV. This is 
likely caused by an activated mitotic checkpoint in Polrt +/+ Pol/- cells, in contrast to our 
findings in Polrt-/- cells. This difference in response is likely due to the major role in UV 
DNA damage tolerance played by Pol 11; in the presence of Pol 11, Poll plays only a 
minor catalytic role in TLS at the replication fork. In the absence of Pol 11 (XP variant), 
cells rely on Pol 1 to perform TLS across from UV lesions. It is possible that Pol 1 is 
required to signal G2 arrest for postreplication repair, when TLS is performed in G2 
phase after semiconservative DNA synthesis has left single-strand gaps in DNA across 
from lesions. Loss of Poll could fail to trigger this checkpoint and allow a cell with 






Ultraviolet radiation (UV) is the most ubiquitous environmental carcinogen and is 
clearly linked to the etiology of skin cancer in humans [139]. The UV spectrum is 
divided into low-energy UV A (320-400 nm), mid-range UVB (295-320 nm), and high-
energy uve (100-295 nm). Wavelengths below 300 nm are completely filtered out by 
ozone in the atmosphere between 10 and 50 km above the earth's surface, along with a 
large portion of the UVB component of solar radiation [140](Fig 3-1). While only 10% 
of the UV radiation reaching the earth's surface is UVB, this component is still the major 
cause of sunburn and skin cancer. UV wavelengths of -295 nm (UVB) are -1O,OOO-fold 
more potent in causing cancer that those> 340 nm (UV A) [141 ](Fig 3-2). UV exposure 
acts as a complete carcinogen; the DNA damage induced by higher energy UVB rays 
causes mutations in protooncogenes and tumor suppressors [139,142], and long-term 
exposure causes immunosuppression and tumor promotion [143]. Human exposure 
levels are typically measured in terms of the minimal erythema dose (MED) for the skin 
type being exposed. For a person with skin type I ("always bums, never tans"), the MED 
is 200 J/m2. Over the Fourth ofJuly weekend in 2010, maximum UV fluxes achieved, 
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Fig. 3-1. UV spectrum and effects on terrestrial absorption. uve and some UVB 
wavelengths are filtered by ozone in the atmosphere. UVB is primarily responsible for 
UV-induced cancer, while UV A is primarily responsible for photoaging. Adapted with 
permission from Fiedberg et al [100]. 
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Fig. 3-2. Skin Cancer Utrecht-Philadelphia (SCUP) action spectrum for hairless albino 
mice. Data were collected from 14 UV sources and about 1100 mice to generate an 
action spectrum for the induction of skin cancer by UV light in mice. Adapted from de 
Gruij 1, Cancer Res 1993 [141] with permission. 
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J/m2*min in Waimea, Hawaii, 18 J/m2*min in Homestead, Florida, and 15 J/m2*min in 
West Lafayette, Indiana [144]. At these levels of exposure, it would take as little as eight 
minutes for sun damage to occur to unprotected skin of type I. In vivo studies of 
photocarcinogenesis utilize sub erythemal doses of UV to avoid the massive stimulation 
of the immune system triggered by the sunburn response. In this dissertation, the daily 
doses of 50 J/m2 UVB were approximately 20-fold lower than the MED of the animals 
being treated. 
It is important to note that most studies of cells in culture, including those in this 
dissertation, make use of high-energy UVC lamps with emission peaks at 254 nm due to 
the high efficiency of absorption of DNA (260 nm absorption peak). Despite the fact that 
this exposure is not physiologically relevant, 254 nm UVC radiation is highly specific for 
inducing DNA damage and is therefore an ideal genotoxicant for DNA repair studies. In 
addition, the true environmental carcinogen UVB also induces 6-4 photoproducts and 
CPDs in the same relative frequency as UVC, although with less efficiency [65,145]. 
Evidence also shows that UVC can generate the oxidate damage that is the hallmark of 
UV A exposure and thought to lead to the phenomenon of skin ageing, although with a 
different frequency [146]. Thus, while treating cells in culture with UVC is not 
physiologically relevant, this genotoxicant is chosen as a precision tool to induce almost 
exclusively damage to the DNA, and results obtained from these studies must be 
considered in that context. 
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NONMELANOMA SKIN CANCER 
Skin cancer is divided into two basic categories: melanoma and nonmelanoma 
skin cancer (NMSC). NMSC is the most prevalent cancer in the world and is further 
divided into basal cell carcinoma and squamous cell carcinoma (SCC). More than six 
million cases of nonmelanoma skin cancer were diagnosed in the US in 2006, and the 
number of cases continues to rise annually [147,148]. Up to one-fifth of seventy-year-
olds have had at least one NMSC diagnosis [149]. Despite the low mortality of the 
disease, it still poses a significant public health burden due to the number of affected 
individuals. Direct costs attributable to NMSC treatment in the US were nearly $1.5 
billion in 2004 and are primarily made up by office visits for outpatient surgeries [150]. 
Pol t is implicated in error-prone TLS ofUV-induced DNA damage in 
vivo. While Pol11-deficient mice develop cancer rapidly due to high UV -induced 
mutation frequencies, loss of Pol t causes both a reduction in cancer latency and mutation 
frequency [62,63,64]. This remarkable finding indicates that Pol t could have a role 
outside ofTLS, but the conclusion is limited due to the fact that the phenotype was only 
observed with concurrent deletion of Pol 11. The studies in this chapter were designed to 
address the hypothesis that Pol t deficiency decreases UV-induced tumor latency. 
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Materials and Methods 
Mouse Model 
All animal studies were approved by the Institutional Animal Care and Use Committee at 
the University of Louisville. Pol/- 129/SvJ mice [59] were purchased from Jackson 
Laboratories (Bar Harbor, Maine), and PollJ-1- mice [19] were a gift from Raju 
Kucherlapati (Harvard University). SKHlIhairless Xpa-I- mice [151] were a gift from 
Harry van Steeg (Leiden University Medical Centre). PollJ-1- and Pol(l- 129/SvJ mice 
were each backcrossed for seven generations with SKHlIhairless Xpa-I- mice. Resultant 
isogenic genotypes were Xpa-I- PollJ +1+ Poll +1+ controls, Xpa-I- PollJ-1- Poll +1+, and Xpa-I-
P I +1+ P 1-1-OIJ 01. 
UV Irradiation 
Mice were irradiated with a bank of two UVM-225D bulbs with peak emission at 302 nm 
(UVP, Upland CA). UV flux was measured using an IL1700 radiometer with a UVB-l 
sensor fitted with a WI diffuser (International Light, Peabody, Massachusetts). The 
sensor measures the output at 313 nm. Mice were irradiated with 50 J/m2 five days per 
week for 12 weeks and monitored for tumor growth twice weekly. This dose is well 
below the MED of -1,000 J/m2. Animals were euthanized 20 weeks after the start ofUV 
or when one tumor reached> 1 0% of body mass. The animals were photographed and 




Xpa-I- mice developed tumors with 100% penetrance and short latency, with all 
mice bearing one tumor by 15 weeks after UV treatment started (Fig. 3-3). Xpa-I- Polr( 
mice developed cancer faster than Poill-proficient controls, with all mice bearing at least 
one tumor by 12 weeks (p < 0.01). Xpa-I- Pol(l- mice all had one tumor by 13.6 weeks, a 
reduction in tumor latency that that trended towards significance (p = 0.057). This is the 
first time that loss ofPolt as the only TLS polymerase has been shown to reduce UV-
induced tumor latency. 
Histopathological analysis revealed no distinct differences among genotypes of 
mice (n = 10 tumors per genotype, Fig. 3-4). All tumors analyzed were Sec. We did not 
observe the highly aggressive spindle cell tumors in Poh-I- mice reported by others [64]. 
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Fig. 3-3. UV-induced carcinogenesis in Xpa-I - mice. Kaplan-Meier plot induced by 12 
weeks of treatment with 50 J/m2 five days per week. Survival is defined as the fraction of 
tumor-free mice. n = 26 (Xpa-/") , 25 (Xpa-I- Polr( ), and 33 (Xpa-I- Pol(I-). Overall (3 
group) p =.0002. Xpa-I- Poli-I- vs. Xpa-I- : p = .057. Xpa-I- Poli"/- vs. Xpa-I- Polh-I-: p = 
.026. Xpa-I- Polh-I- vs. Xpa-I-: p = .008. 
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40X 200X 
Fig. 3-4. Histopathology of squamous cell carcinoma in Xpa-I- mice. Ten tumors from 
each genotype were sectioned and stained with H&E for blinded pathological analysis. 
All tumors were locally invasive squamous cell carcinoma. 
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DISCUSSION 
It is well known that loss of Pol 11 results in dramatically reduced UV-induced 
skin cancer latency in humans [35] and mice [19]. Pol 11 appears to be evolutionarily 
conserved [13] to perform accurate bypass ofUV-induced DNA damage [41,42,43,128], 
but much less is known about the effect of the error-prone POll in animals. We have 
demonstrated that loss of POll causes a trend toward decreased tumor latency (Fig 2-3). 
This was an intermediate phenotype compared to the Polr( mice. These studies support 
our hypothesis that POll suppresses formation ofUV-induced skin cancer, This 
hypothesis was based on the previous finding that Polr( Pol/- double knockout mice 
develop tumors faster than Pob( Poll +1+ mice, despite reduced UV -induced mutation 
frequencies in Pol,,-I- cells [63]. 
The reason we did not find a significant difference between Xpa-I- and Xpa-I- Pol( 
1- mice is possibly due to the small effect sizes that result from the Xpa-I- background. 
C57B1I6 mice are resistant to UV -induced skin cancer, and wild type animals usually do 
not develop tumors even after months of chronic UV exposure [19]. It is for this reason 
that previous studies could not assess the effect of Poll-1- on UV carcinogenesis; neither 
wild-type nor Pol(l- mice developed tumors [63]. We backcrossed Pol,,-I- and Pol/- into 
the SKHlIhairlessXpa-l- background, which is highly susceptible to UV-induced SCC 
[151]. As a result, the difference in tumor latency between the control and experimental 
groups is very small. It is also possible that the severe phenotype of complete NER-
deficiency in the Xpa-I- controls partially masks the phenotype of POll knockout. Using 
Xpa-wild type mice, which develop tumors after approximately 20 weeks of chronic UV 
treatment, as controls could increase the effect size of Po 1(1- knockout and the 
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significance of the difference between groups. It is also possible that we did not have 
significant numbers of mice per group to detect a significant difference. We did perform 
a power analysis in collaboration with the Statistical Consulting Center at the University 
of Louisville School of Medicine, estimating an effect size based on previous data from 
our lab [63]. We determined that a sample size of28 mice per group would provide 80% 
power for pairwise two-sided log rank test to detect differences in tumor latency at a 
significance of 0.05. Based on the smaller effect sizes in this study and the fact that our 
control and Xpa -1- Pob( group were under-populated, it is possible that increasing the 
number of mice in these groups, or all three groups would bring the p-value below 0.05. 
Our histopathological analysis indicated that Polrt and PO/{I- mice develop the 
same locally invasive SCC as Xpa-I- control mice. This finding is in agreement with a 
previous report from Dumstorf et al [63], but conflicts with the findings of aggressive 
spindle cell tumors in Pol/- mice found by Ohkumo et al [64]. One possible explanation 
of the discrepancy among findings of tumor pathology in these studies is the background 
of the mice used; Ohkumo et al used isogenic Polr( and Pol/- mice in a C57Bl/6 
background [64], and mice in this study were isogenic in the SKHlIhairless Xpa-I-
background. Dumstorf et al used mixed backgrounds for carcinogenesis studies. Wild 
type and PollJ-1- mice were C57B1I6, and Pol(l- mice were 129 background. Double 
knockout mice were in a hybrid C57B1I6 X 129 X B6 background from an F2 generation 
backcross [63]. The spindle cell tumors were only observed in Po/z-I- mice [64], which 
were in a C57B1I6 background in that study. The fact that Pol/- mice are in different 
backgrounds in both this study and in Dumstorf et al is a confounding factor in 
comparing the results of these three carcinogenesis studies. 
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We also carefully examined all tumors for the presence of multinucleated cells. 
Based on our findings of increased binucleated cells in the Pol/- genotype (Fig. 2-10), 
we expected that tumors from Xpa-I- Pol,-I- mice would exhibit binucleated cells. The fact 
that we did not find evidence ofbinucleated cells or multinucleated tumor giant cells 
could be a result of the long period of time between tumor initiation and histopathological 
analysis (as long as 15 weeks for Xpa-I- Polr(- andXpa-l - Pol/- mice). Also, our studies 
in Chapter II were also based on primary fibroblasts in culture, whereas the tumors 
analyzed in this study are epithelial in origin. It is possible that the POll has a cell-type 
specific role in regulating cytokinesis; however, we also analyzed fibroblasts in the 
basement membrane below the tumors and found no evidence ofbinucleated or 
multinucleated cells. Another possible explanation is the strain of the mice used, since 
cells used in Chapter II were isolated from the mixed background mice described in 
Dumstorf et al [63]. Strain differences are a confounding factor when comparing the cell 
culture studies that showed impaired cytokinesis in Pol,-I- cells and in vivo studies with 
isogenic SKHl/hairless Xpa-I- mice which did not confirm these findings. More direct 
studies are needed to address the role of Pol 1 in regulating cytokinesis in live animals, 
but this study does support our hypothesis that POll suppresses UV -induced 





Mutagenesis is a recognized cornerstone of every form of human cancer [152] 
dating back to the discovery of aneuploidy in cancer cells [153]. According to the 
modem somatic mutation hypothesis of cancer, a cell must undergo several independent 
genetic and epigenetic events that together confer properties associated with the 
malignant phenotype. These include acquisition of infinite lifespan, resistance to 
apoptotic signals, growth factor independence, resistance to anti growth signals, 
angiogenesis, and tissue invasion [1]. Acknowledgment of the critical role of mutations 
in carcinogenesis opens the possibility of chemoprevention using antimutator strategies. 
Although recent advances have elucidated key details of the pathways underlying 
mutagenesis, there exist critical gaps in our knowledge of the fundamental mechanisms 
by which DNA is mutated during carcinogenesis. In this thesis, we will investigate how 
environmental carcinogens permanently alter the sequence of DNA in order to cause 
cancer. 
Benzo[a]pyrene (B[a]P) is also a well-studied skin carcinogen. It is clear that 
anti-benzo[a]pyrene-7,8-diol-9,1 O-epoxide (BPDE), a metabolic derivative ofB[a]P, is 
the ultimate carcinogen [154,155]. BPDE formation proceeds through the action of 
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CYP450, microsomal epoxide hydratase, and repeated CYP450 oxidation (reviewed in 
[156]). Carcinogenic activity ofB[a]P is primarily due to in vivo binding of the ultimate 
carcinogen to DNA to form bulky adducts [155]. As analyzed by 32P-postlabeling, 
stable BPDE-N2-dG adducts constitute over 98% of adducts formed in mouse skin 
treated with anti-BPDE [157]. However, other reports indicate that multiple other 
adducts are formed by B[a]P in mouse skin and may be at a higher frequency than 2% 
[158,159]. These adducts are normally recognized and repaired by enzymes in the NER 
pathway. Purified Pol 1'] and Pol t perform well-characterized error-prone bypass of 
BPDE lesions in vitro [77J, but this chapter is designed to address the hypothesis that 





Poly! knockout mice were recently generated by our collaborators in a C57Bl/6 hybrid 
background [19]. To generate polrl-I-poh-I- double knockouts, these animals were bred 
with 129/0la mice, which have been shown to carry a nonsense mutation in poh resulting 
in a protein truncated at Ser-27 [59]. Primary fibroblasts have been isolated from these 
mice and used for mutagenesis studies in our laboratory [63], and these cells were used in 
this Chapter. Mouse fibroblasts were grown in monolayer cultures using a-MEM 
supplemented with non-essential amino acids, penicillin-streptomycin and 10% fetal 
bovine serum. They were maintained in exponential growth. We routinely grow primary 
murine cells in a 3% 02/5% C02/92% N2 atmosphere [132]. 
Hprt mutagenesis 
For genotoxicant treatment, cells were plated at 1 x 104 cm-2. The culture media was 
removed and cells were washed twice with sterile phosphate-buffered saline (PBS, pH 
7.4). Serum-free media was added to the cells along with each chemical carcinogen for a 
period of one hour. We used 150 nM BPDE for survival and mutagenesis studies. After 
one hour of treatment, the culture media was aspirated followed by two washes in PBS. 
For cytotoxicity, cells were trypsinized and counted, then replated at cloning density (the 
exact number depends on the expected survival). After two weeks, plates were stained 
with 1 % crystal violet and counted. For mutagenesis, cells were maintained in 
exponential growth for eight days after treatment, after which we trypsinized, counted, 
and selected I X 106 cells with 20 /lM 6-thioguanine at a density of 3000 cm-2. After 2 
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weeks of selection, we isolated individual TGT clones, trypsinized, and resuspended them 
in RNase-free PBS. The technique for amplifying the hprt gene was performed as 
described [160] with modifications routine in our laboratory [90]. Briefly, TGr colonies 
were pelleted at 4°C and the PBS removed. The cells were directly lysed and cDNA 
generated using a cDNA cocktail. After incubation at 37°C for 1 h amplification was 
performed using a Taq polymerase cocktail and two outer primers. The 5' primer is from 
position -47 to -28 relative to the start codon (GGC TTC CTC CTC AGA CCG CT). The 
3' primer is from position 790 to 771 (ACA TCA ACA GGA CTC CTC GT). 
Reamplification using an inner primer set (5', from -27 to -8, TTT TGC CGC GAG CCG 
ACC GG and 3', from 770 to 751, ATT TGC AGA TTC AAC TTG CG) will follow. The 
PCR products were sequenced with each of the inner primers using an ABI 370 
automated DNA sequencer and dRhodamine dye terminator chemistry. 
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RESULTS 
Fig. 4-1 shows clonogenic survival of wild type; Polr( Polz +1+, PolY/ +1+ Po 1/-, 
and Poly/-I- Pol/- cells treated with 150 nM BPDE. There were no differences in BPDE-
induced cytotoxicity. Hprt-induced mutation frequencies are shown in Fig. 4-2. Loss of 
Pol 11 or Pol 1 alone reduced mutation frequencies by ~80%; double knockout cells 
displayed mutation frequencies similar to those of the single knockouts. Mutation 
frequencies were 191,34,44, and 56 TGT mutants per 106 clonable cells in wild type, 
Poly/-I-, Pol/-, and double knockout cells, respectively. These data support our 
hypothesis that POll participates in error-prone TLS of BPDE-induced lesions, probably 
in coordination with Pol 11 due to the similar phenotype of the Pol 11-knockout and the fact 
that the double knockout cells have the same mutation frequency. Table 4-1 summarizes 
Hprt sequencing data from TGT clones. These data indicate that the polymerase 
responsible for making mutations opposite the bulky BPDE-DNA lesion in both wild 
type and POly/-I- cells has a similar mutation spectrum. The percentage of frequent uv-
induced mutations such as C--+ T transitions and G--+ T transversions were very similar 
between genotypes despite the dramatic reduction in the mutation frequency in POly/-I-
cells. However, tandem mutations (10.5%) were only found in the wild type cells, and 
small deletions (5.6%) were only found in Polr( cells. The number ofTGT clones 
analyzes was insufficient for statistical analysis. Due to consistently low replating 
efficiency, insufficient clones could be isolated from PolY/ +1+ POl,-l- and POly/-I- Poll-I- cells 
for analysis. 
Table 4-2 lists the mutant Hprt sequences from TGT clones. Specific analysis of 
the sequence data reveals similar distribution of mutations throughout the Hprt gene. We 
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did find that the only mutations arising from adducts in the transcribed strand were in 


















WT Il- l- Il-l-
Fig. 4-1. Loss of Pol 11 or Pol t does not affect BPDE-induced cytotoxicity. Primary 
dermal fibroblasts isolated from mice of the indicated genotypes were treated with 150 
nM BPDE at 104 cm-2 and immediately replated at cloning density. Cells were refed after 
seven days and stained with crystal violet after 14 days to determine clonogenic survial. 
There were no significant differences in clonogenic survival among the genotypes. 
Average survivals were calculated based on results from at least four independent 
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WT Il- l- r}-l-
Fig. 4-2. Loss of Pol 11 or POll dramatically reduces BPDE-induced mutagensis. 
Primary dermal fibroblasts isolated from mice of the indicated genotypes were treated 
with 150 nM BPDE at 104 cm-2. After eight days of exponential growth, cells were 
replated in 40 11M 6-thioguanine and grown for two weeks. Thioguanine-resistant clones 
were stained with crystal violet. There Averages represent at least three independent 
experiements. Histogram bars with different letters are significantly different (p<0.05) . 
Error bars, SEM. 
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VVjld Type Pol!,}---
Independen Percent of Independent Percent of 
rJlutation Type Clones Total Clones Total 
Transitions ~ 21 1 5 2 8 
A-T - G·C 1 53 2 11 1 
G·e - A·T 3 158 3 16 7 
Trans"ersions 13 68 4 12 667 
A-T - e -G 2 105 0 00 
A-T - T-A 1 53 0 00 
G·C - T-A 10 526 11 61 1 
G·C - C·G 0 00 1 56 
Tandem 2 105 0 00 
Small Deletion 0 00 1 56 
Total 19 1000 18 100 0 
Table 4-1. Summary of BPDE-induced mutations. Isolation and sequencing of Hprt 
cDNA from thioguanine-resistant clones indicated that the mutation spectrum of BPDE is 
similar in both wild type and Polr( cells . Tandem mutations were only seen in the wild 
type cells (10.5%), whi le only one deletion mutation was seen in the Polr( cells (5 .6%). 
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W-'dT , Ivoe PI f. O[ll: • 
Sampl@ Mutation Typ@ Nucl@otid@ Strand Sampl@ Mutation Typ@ Nucl@otid@ Strand 
35-0-1 A>C ~~9 T ~S3-2-t A>G 155 1fT 
35d-l A>C ~~9 T C1 A>G -t97 lIT 
68-32 A>G ~91 T -tSa-28 G Deletion 337 1fT 
83-2 A>T 1 lIT 483-26 G>A 197 1fT 
68-13 G>A 2Z 1fT A1 G>A 209 lIT 
68·7 G>A 617 1fT 48a-l0 G>A 27 1fT 
68-U G>A 617 1fT 48-1A-6 G>C 566 1fT 
35d-2 G>T 197 IJT 48a-19 G>T 119 liT 
68-3 G>T 197 liT H1 G>T 123 lIT 
68-2 G>T 230 lIT C G>T 129 lIT 
68-6 G>T 419 1fT 48-1A-1 G>T 208 lIT 
66-19 G>T 563 I-JT 48a-14 G>T 208 lIT 
68-35 G>T 569 lIT 81 G>T 212 liT 
68-33 G>T 601 lIT 48a-25 G>T 3 1fT 
68-9 G>T 617 lIT G1 G>T 398 IJT 
68-15 G>T 624 liT 48·18·3 G>T 420 1fT 
83·18 G>T 88 IJT H G>T 569 1fT 
68-26 CG»GT 612-3 m 48a·33 G>T 88 1fT 
68-25 GG»CC ~18 ·9 IJT 
Table 4-2. Hprt mutant sequences_ Isolation and sequencing of individual thioguanine-
resistant clones after BPDE treatment revealed that the mutation spectrum in wild type 
(n= 19 unique mutations) and POly/-I- Pob +1+ cells (n= 18 unique mutations) both consisted 
primarily of G>T transversions originating from BPDE lesions on the nontranscribed 




Purified Pol t has been characterized in the error-prone bypass of BPDE lesions 
[77], but the cellular role of this enzyme in bypassing bulky adducts induced by 
environmental carcinogens remains unclear. As a first step towards extending our UV 
studies to carcinogenesis by B[a]P, we first characterized the cellular role of Pol t after 
treatment with the active metabolite BPDE. Using primary ear fibroblasts from Polr( 
and Pol/- mice, we discovered that loss of either enzyme reduced the mutation frequency 
induced by 150 nM BPDE by approximately 80%. The mutation frequency in the double 
knockout cells was indistinguishable from either single knockout, indicating that Pol 11 
and Pol t are epistatic in the bypass of BPDE lesions. In the absence of either Pol 11 or 
Pol t, it is likely that Pol K performs bypass ofBPDE DNA damage. Purified Pol K 
bypasses BPDE lesions in an accurate manner [76,77,161], and experiments in PoIK-1-
mouse embryonic fibroblasts show elevated BPDE-induced mutation frequency in the 
absence of this enzyme [81]. The faithful nature of Pol K BPDE lesion-bypass could 
explain the low mutation frequency in Pob( and Pol(l- cells. 
The mechanism of bypass involving both Pol 11 and Pol t is possibly a two-step 
model ofTLS [161] where both enzymes are a part of the molecular complex required for 
efficient bypass synthesis. Following this model, Pol 11 would perform direct lesion 
bypass synthsis, frequently making errors [77]. Pol K or 1;; could perform the extension 
step and leave a suitable DNA template for the continuation of normal replication. It is 
unlikely that Pol t is involved in the direct bypass of BPDE due to the fact that the 
purified protein is blocked by this adduct [77]. Pol t has also never been characterized as 
an extender in a two-polymerase model, so it is likely that Pol t is not involved in the 
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extension step ofBPDE bypass. Since POll is not likely to be directly involved in BPDE 
bypass synthesis and yet its absence still results in reduced mutation frequency, we 
hypothesize that this protein is a necessary component of the TLS complex. Without Pol 
1, the multi subunit complex necessary for the proposed two-step bypass of BPDE could 
become unstable, allowing the direct bypass synthesis by the secondary Y -famly Pol K. 
The relative fidelity of Pol K on the BPDE lesion template would explain the reduced 
mutation frequency in our Pob'( and Pol/- cells. 
It is important to note that Y-family polymerases are recruited to stalled 
replication forks by protein-protein interactions. Y -family polymerases all have novel 
ubiquitin binding regions which mediate their preferential binding to monoubiquitylated 
PCNA [75], a post-translational modification that is made by the Rad6/Rad18 complex 
after replication fork stalling. This interaction with monoubiquitylated PCNA appears to 
be critical to the initiation ofTLS. It has also been shown that Rad18 directly shuttles 
Pol TJ to the site of replication forks stalled at UV -induced DNA damage [44]. This 
interaction is mediated by the preferential interaction of Pol TJ with phosphorylated Rad18 
[162]. The demonstrated central role of protein-protein interactions in promoting 
functional TLS indicates that the proposed model ofBPDE bypass requiring both Pol TJ 
and POll for the stability of a multi protein complex is plausible. 
Another explanation for the very low mutation frequency in cells lacking Pol TJ 
and/or POll is that BPDE lesions are tolerated using template switching, an error-free 
method of damage avoidance where the nascent DNA strand is used as an undamaged 
homologous template. Replacing mutagenic TLS with error-free template switching 
could also account for the reduced mutation frequency in Polr( andPo/z-1- cells. This 
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method of damage avoidance is likely to increase at least slightly in our knockout cells if 
our hypothesis of an unstable TLS complex is true, as even accurate TLS by Pol K would 
require association with such a multiprotein complex to function. 
Despite the fact that the number of TGf clones isolated was too small for 
statistical analysis, we can draw some conclusions about the nature of the mutation 
spectrum of the active V-family polymerase in each genotype examined. Wild type and 
Polr( Poll +/+ cells showed mutation spectra that were very similar. This suggests that 
Pol 11 either does not directly catalyze TLS across from BPDE lesions, or another 
polymerase takes over TLS in its place with the same mutation spectrum. If Pol 11 is not 
directly involved in the lesion bypass step, the most likely enzyme to perform this 
function would be Revl. Evidence in yeast indicates that Rev1 is required with Pol 11 and 
Pol K for mutagenic BPDE bypass [31]; it is therefore possible that both Pol 11 and Pol t 
are necessary for the formation of a TLS complex, and that loss of either enzyme results 
in a disruption in this predominant mutagenic bypass pathway. There was a trend 
towards increased tandem mutations in wild type cells (% of total) versus small deletions 
in Polr( cells, which could indicate a change in the active bypass polymerase. This 
slight change in mutation spectrum could suggest that Pol 11 is the active bypass 
polymerase in wild type cells and displays relatively high processivity on the BPDE 
lesion template, rarely adding two incorrect bases rather than one. In Polr( cells, Rev 1 
could perform mutagenic lesion bypass, preferentially skipping a base a causing a 
deletion and giving rise to the shifted mutation spectrum. 
While we were able to isolate and sequence approximately equal numbers of TGf 
clones from wild type and Polr( cells, we repeatedly encountered low replating 
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efficiencies in the thioguanine selection of Pol(/- and Polr/ Pol(/- cells. We optimized 
the TG dose and selection time in an attempt to make the clones more easily visible for 
isolation, but the small number ofTGT clones we were able to isolate did not yield cDNA 
of sufficient quality for peR amplification of the Hprt gene. 
In conclusion, we have shown that Pol l) and Pol 1 participate in mutagenic 
translesion synthesis past BPDE-induced DNA damage. These two enzymes likely 
participate in the same mutagenic bypass pathway, such that loss of either Poll) or Poll 
disrupts mutagenic TLS and allows for a more faithful damage tolerance mechanism, 
likely TLS by Pol K or template switching. This is the first indication that Pol 1 is 
involved in the cellular response to BPDE; it also represents the first step in applying our 
findings from studies of Poll in a UV model to the effects ofBPDE. 
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CHAPTER V 
CONCLUSIONS AND FUTURE DIRECTIONS 
The role of Y -family polymerases is expanding rapidly to include somatic 
hypermutation [21], nucleotide excision repair synthesis [83], and cell cycle checkpoint 
function [80]. Despite great advances in our understanding of the roles of these enzymes 
in mammalian systems, the cellular role of Pol t remains unknown. The purified protein 
has been characterized in the inaccurate bypass of numerous damaged DNA templates 
[77,163,164,165]. It is also known that Pol t is responsible for the high UV -induced 
mutation frequency in XP variant patients who lack Pol 11 [62]. 
Studies in this dissertation were designed to investigate the potential role of Pol t 
outside TLS. Our hypothesis that Pol t could have a role in regulating other cellular 
functions was based on a previous report [63] that Poh-/- have reduced UV-induced 
mutations in their cells, but the mice develop cancer more quickly. We have evidence, 
discussed in Chapter II, suggesting that the disparity between mutation frequency and 
tumor latency is due to the regulation of the mitotic spindle checkpoint by Pol 1. This 
finding is unexpected and novel, and bears further investigation; important questions 
remain about the mechanism of checkpoint regulation by Pol 1. Our initial findings 
should first be replicated in another cell type, preferably human. Then the function of the 
spindle assembly checkpoint could be directly analyzed after genetic manipulation of the 
cells; Poll or Rad18 knockdown could be used as specific and general TLS inhibitors, 
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and cytochalasin B or aurora B kinase inhibitors could be used to block cells at 
cytokinesis. Fluorescent tagged recombinant POll could be expressed in synchronized 
cells for the examination of Pol 1 at the kinetochore. The purpose of these proposed 
studies is to determine the exact nature of the regulation of the mitotic checkpoint by Pol 
1. Plosky et a/ reported that ~ 30% of Poli clones in a yeast two hybrid screen were found 
to interact with clones encoding ubiquitin precursor proteins [166]. Therefore, it is 
possible that ubiquitin signaling could playa role in the activity of POll in mitotic 
checkpoint regulation. It is also interesting to note that Pol TJ-deficiency caused a slight 
but significant increase in the percentage ofbinucleated cells. Future studies should 
investigate whether Pol TJ also plays a role in the regulation of the mitotic checkpoint, and 
whether this regulation involves the entire Y family ofpolymerases or is linked to TLS. 
We found in Chapter III that loss of Pol 1 in an isogenic, cancer prone background 
caused a trend towards reduced cancer latency in mice. It is possible that the Xpa-
deficiency of this model rendered the effect sizes too small for statistical differences 
between groups to be realized with the sample sizes used. Therefore, we propose future 
studies using isogenic Xpa +1+ mice to increase the latency of the control group and 
therefore increase the effect sizes of the experimental groups. Future studies should also 
include at least 30 mice per genotype in order to be sufficiently powered to detect 
differences among groups. One major question raised in Chapter III is why we did not 
see multinucleated cells inXpa-l - Poh-I - mice. Future studies should investigate tissues of 
Po/(I- mice in multiple strains in order to determine if background differences playa role 
in the observed discrepancy between our cell culture and in vivo data. 
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In Chapter IV we analyzed the role of Polland Pol 11 in BPDE mutagenesis. We 
propose that these studies serve as the foundation for future work into Poll-mediated 
regulation ofBPDE-induced checkpoints. It is known that Pol K is required for escape 
from an intra-S phase checkpoint induced by BPDE [80], but future studies on POll 
should focus on activation of the mitotic checkpoint. It is feasible that POll is active in 
the regulation of cytokinesis in more conditions that UV -induced DNA damage. It would 
therefore be of interest to examine whether BPDE activates the mitotic checkpoint in 
wild type cells, which has not been studied, and whether loss of POll alters this activity. 
In conclusion, we have found a novel role for the Y-family DNA polymerase 1 in 
activating the mitotic spindle assembly checkpoint after UV -induced DNA damage. In 
the absence of POll, cells proceed through mitosis but do not undergo cytokinesis and 
give rise to a tetraploid population. This is one possible explanation of the observed 
tumor suppressor function of Polz in previous studies [63,64]. In Poll-deficient-mice, we 
found a strong trend towards decreased latency ofUV-induced tumors. Finally, we found 
that POll is involved in mutagenic TLS of BPDE-induced DNA damage. These studies 
support POll as an important candidate for future investigation and a potentially and as 
yet unrecognized regulator of mitotic progression. 
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bromodeoxyuridine 
cyclobutane pyrimidine dimer 
fluorescence activated cell sorting 
false discovery rate 
hypoxanthine guanine phosphoribosyltransferase 
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in vitro transcription 
minimal erythemal dose 
nucleotide excision repair 
proliferating cell nuclear antigen 
DNA polymerase zeta 
DNA polymerase eta 
DNA polymerase iota 
DNA polymerase kappa 
single nucleotide polymorphism 
small ubiquitin-like modifier 
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UTR untranslated region 
UV ultraviolet radiation 
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